AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|YEAR
0-14|143.4|149.8|146.6|8188|All ICCC Groups Combined|55995049|1999
0-19|157.0|162.7|159.8|11918|All ICCC Groups Combined|74706728|1999
0-14|44.2|47.8|46.0|2573|I Leukemias, myeloproliferative & myelodysplastic diseases|55995049|1999
0-19|39.8|42.7|41.2|3077|I Leukemias, myeloproliferative & myelodysplastic diseases|74706728|1999
0-14|34.5|37.7|36.1|2020|I(a) Lymphoid leukemias|55995049|1999
0-19|29.3|31.8|30.6|2284|I(a) Lymphoid leukemias|74706728|1999
0-14|7.0|8.5|7.7|429|I(b) Acute myeloid leukemias|55995049|1999
0-19|7.5|8.8|8.1|606|I(b) Acute myeloid leukemias|74706728|1999
0-14|0.4|0.9|0.6|35|I(c) Chronic myeloproliferative diseases|55995049|1999
0-19|0.8|1.3|1.0|76|I(c) Chronic myeloproliferative diseases|74706728|1999
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|55995049|1999
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74706728|1999
0-14|1.1|1.8|1.4|79|I(e) Unspecified and other specified leukemias|55995049|1999
0-19|1.1|1.6|1.3|100|I(e) Unspecified and other specified leukemias|74706728|1999
0-14|14.5|16.6|15.5|867|II Lymphomas and reticuloendothelial neoplasms|55995049|1999
0-19|22.4|24.6|23.5|1752|II Lymphomas and reticuloendothelial neoplasms|74706728|1999
0-14|4.9|6.2|5.5|308|II(a) Hodgkin lymphomas|55995049|1999
0-19|11.2|12.8|12.0|893|II(a) Hodgkin lymphomas|74706728|1999
0-14|5.4|6.7|6.0|338|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|55995049|1999
0-19|7.1|8.4|7.7|576|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74706728|1999
0-14|2.1|3.0|2.5|143|II(c) Burkitt lymphoma|55995049|1999
0-19|2.1|2.8|2.4|183|II(c) Burkitt lymphoma|74706728|1999
0-14|0.7|1.2|0.9|52|II(d) Miscellaneous lymphoreticular neoplasms|55995049|1999
0-19|0.5|0.9|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|74706728|1999
0-14|0.3|0.7|0.5|26|II(e) Unspecified lymphomas|55995049|1999
0-19|0.5|0.8|0.6|46|II(e) Unspecified lymphomas|74706728|1999
0-14|30.2|33.2|31.7|1776|III CNS and misc intracranial and intraspinal neoplasms|55995049|1999
0-19|27.5|30.0|28.7|2149|III CNS and misc intracranial and intraspinal neoplasms|74706728|1999
0-14|2.5|3.4|2.9|164|III(a) Ependymomas and choroid plexus tumor|55995049|1999
0-19|2.2|3.0|2.6|194|III(a) Ependymomas and choroid plexus tumor|74706728|1999
0-14|13.4|15.4|14.4|805|III(b) Astrocytomas|55995049|1999
0-19|12.7|14.4|13.6|1013|III(b) Astrocytomas|74706728|1999
0-14|7.2|8.7|7.9|444|III(c) Intracranial and intraspinal embryonal tumors|55995049|1999
0-19|6.1|7.3|6.7|503|III(c) Intracranial and intraspinal embryonal tumors|74706728|1999
0-14|4.6|5.9|5.2|293|III(d) Other gliomas|55995049|1999
0-19|4.2|5.2|4.7|353|III(d) Other gliomas|74706728|1999
0-14|0.3|0.7|0.5|29|III(e) Other specified intracranial & intraspinal neoplasms|55995049|1999
0-19|0.4|0.7|0.5|38|III(e) Other specified intracranial & intraspinal neoplasms|74706728|1999
0-14|0.5|1.0|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|55995049|1999
0-19|0.5|0.9|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|74706728|1999
0-14|9.7|11.4|10.5|585|IV Neuroblastoma and other peripheral nervous cell tumors|55995049|1999
0-19|7.5|8.8|8.2|606|IV Neuroblastoma and other peripheral nervous cell tumors|74706728|1999
0-14|9.5|11.3|10.4|576|IV(a) Neuroblastoma and ganglioneuroblastoma|55995049|1999
0-19|7.2|8.5|7.9|584|IV(a) Neuroblastoma and ganglioneuroblastoma|74706728|1999
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|55995049|1999
0-19|0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|74706728|1999
0-14|8.6|10.3|9.4|527|IX Soft tissue and other extraosseous sarcomas|55995049|1999
0-19|10.1|11.6|10.8|809|IX Soft tissue and other extraosseous sarcomas|74706728|1999
0-14|4.3|5.5|4.9|273|IX(a) Rhabdomyosarcomas|55995049|1999
0-19|4.0|5.0|4.5|337|IX(a) Rhabdomyosarcomas|74706728|1999
0-14|0.7|1.3|1.0|54|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|55995049|1999
0-19|0.9|1.4|1.2|86|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74706728|1999
0-14|~|~|~|~|IX(c) Kaposi sarcoma|55995049|1999
0-19|~|~|~|~|IX(c) Kaposi sarcoma|74706728|1999
0-14|2.2|3.1|2.6|147|IX(d) Other specified soft tissue sarcomas|55995049|1999
0-19|3.5|4.4|3.9|292|IX(d) Other specified soft tissue sarcomas|74706728|1999
0-14|0.7|1.2|0.9|52|IX(e) Unspecified soft tissue sarcomas|55995049|1999
0-19|1.0|1.5|1.2|91|IX(e) Unspecified soft tissue sarcomas|74706728|1999
0-14|0.2|0.5|0.3|17|Not classified by ICCC|55995049|1999
0-19|0.2|0.5|0.3|23|Not classified by ICCC|74706728|1999
0-14|3.8|4.9|4.3|239|V Retinoblastoma|55995049|1999
0-19|2.8|3.7|3.2|240|V Retinoblastoma|74706728|1999
0-14|7.3|8.8|8.1|450|VI Renal tumors|55995049|1999
0-19|5.8|7.0|6.4|477|VI Renal tumors|74706728|1999
0-14|6.9|8.4|7.6|424|VI(a) Nephroblastoma and other nonepithelial renal tumors|55995049|1999
0-19|5.3|6.4|5.8|433|VI(a) Nephroblastoma and other nonepithelial renal tumors|74706728|1999
0-14|0.3|0.6|0.4|23|VI(b) Renal carcinomas|55995049|1999
0-19|0.4|0.7|0.5|40|VI(b) Renal carcinomas|74706728|1999
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|55995049|1999
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|74706728|1999
0-14|1.7|2.5|2.1|115|VII Hepatic tumors|55995049|1999
0-19|1.7|2.3|2.0|147|VII Hepatic tumors|74706728|1999
0-14|1.4|2.1|1.7|93|VII(a) Hepatoblastoma|55995049|1999
0-19|1.0|1.6|1.3|94|VII(a) Hepatoblastoma|74706728|1999
0-14|0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|55995049|1999
0-19|0.5|0.9|0.7|52|VII(b) Hepatic carcinomas|74706728|1999
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|55995049|1999
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74706728|1999
0-14|6.5|8.0|7.2|404|VIII Malignant bone tumors|55995049|1999
0-19|8.2|9.6|8.9|664|VIII Malignant bone tumors|74706728|1999
0-14|3.7|4.8|4.2|236|VIII(a) Osteosarcomas|55995049|1999
0-19|4.6|5.7|5.1|383|VIII(a) Osteosarcomas|74706728|1999
0-14|~|~|~|~|VIII(b) Chondrosarcomas|55995049|1999
0-19|0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|74706728|1999
0-14|2.0|2.8|2.4|133|VIII(c) Ewing tumor and related sarcomas of bone|55995049|1999
0-19|2.4|3.1|2.7|204|VIII(c) Ewing tumor and related sarcomas of bone|74706728|1999
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|55995049|1999
0-19|0.4|0.7|0.5|38|VIII(d) Other specified malignant bone tumors|74706728|1999
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|55995049|1999
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|74706728|1999
0-14|4.5|5.7|5.0|280|X Germ cell, trophoblastic tumors & neoplasms of gonads|55995049|1999
0-19|9.5|11.0|10.3|762|X Germ cell, trophoblastic tumors & neoplasms of gonads|74706728|1999
0-14|1.0|1.7|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|55995049|1999
0-19|1.2|1.7|1.4|105|X(a) Intracranial & intraspinal germ cell tumors|74706728|1999
0-14|1.1|1.7|1.4|75|X(b) Malignant extracranial & extragonadal germ cell tumors|55995049|1999
0-19|1.1|1.7|1.4|103|X(b) Malignant extracranial & extragonadal germ cell tumors|74706728|1999
0-14|1.8|2.6|2.1|119|X(c) Malignant gonadal germ cell tumors|55995049|1999
0-19|6.2|7.4|6.8|503|X(c) Malignant gonadal germ cell tumors|74706728|1999
0-14|~|~|~|~|X(d) Gonadal carcinomas|55995049|1999
0-19|0.3|0.6|0.4|32|X(d) Gonadal carcinomas|74706728|1999
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|55995049|1999
0-19|0.2|0.4|0.3|19|X(e) Other and unspecified malignant gonadal tumors|74706728|1999
0-14|5.2|6.5|5.9|327|XI Other malignant epithelial neoplasms and malignant melanomas|55995049|1999
0-19|14.6|16.4|15.5|1151|XI Other malignant epithelial neoplasms and malignant melanomas|74706728|1999
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|55995049|1999
0-19|0.1|0.4|0.2|17|XI(a) Adrenocortical carcinomas|74706728|1999
0-14|1.6|2.3|1.9|107|XI(b) Thyroid carcinomas|55995049|1999
0-19|5.4|6.5|5.9|439|XI(b) Thyroid carcinomas|74706728|1999
0-14|0.2|0.6|0.4|21|XI(c) Nasopharyngeal carcinomas|55995049|1999
0-19|0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|74706728|1999
0-14|1.4|2.1|1.8|98|XI(d) Malignant melanomas|55995049|1999
0-19|4.3|5.3|4.8|357|XI(d) Malignant melanomas|74706728|1999
0-14|~|~|~|~|XI(e) Skin carcinomas|55995049|1999
0-19|~|~|~|~|XI(e) Skin carcinomas|74706728|1999
0-14|1.2|1.9|1.5|85|XI(f) Other and unspecified carcinomas|55995049|1999
0-19|3.5|4.4|3.9|291|XI(f) Other and unspecified carcinomas|74706728|1999
0-14|0.3|0.7|0.5|28|XII Other and unspecified malignant neoplasms|55995049|1999
0-19|0.6|1.1|0.8|61|XII Other and unspecified malignant neoplasms|74706728|1999
0-14|~|~|~|~|XII(a) Other specified malignant tumors|55995049|1999
0-19|0.1|0.4|0.2|17|XII(a) Other specified malignant tumors|74706728|1999
0-14|0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|55995049|1999
0-19|0.4|0.8|0.6|44|XII(b) Other unspecified malignant tumors|74706728|1999
0-14|147.0|153.4|150.2|8434|All ICCC Groups Combined|56294656|2000
0-19|161.4|167.2|164.3|12336|All ICCC Groups Combined|75211310|2000
0-14|44.5|48.0|46.2|2591|I Leukemias, myeloproliferative & myelodysplastic diseases|56294656|2000
0-19|40.1|43.0|41.5|3111|I Leukemias, myeloproliferative & myelodysplastic diseases|75211310|2000
0-14|35.8|39.0|37.3|2093|I(a) Lymphoid leukemias|56294656|2000
0-19|30.8|33.4|32.0|2401|I(a) Lymphoid leukemias|75211310|2000
0-14|5.9|7.3|6.6|369|I(b) Acute myeloid leukemias|56294656|2000
0-19|6.5|7.7|7.1|530|I(b) Acute myeloid leukemias|75211310|2000
0-14|0.6|1.0|0.8|43|I(c) Chronic myeloproliferative diseases|56294656|2000
0-19|0.7|1.1|0.9|68|I(c) Chronic myeloproliferative diseases|75211310|2000
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56294656|2000
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|75211310|2000
0-14|1.1|1.7|1.4|76|I(e) Unspecified and other specified leukemias|56294656|2000
0-19|1.1|1.6|1.3|100|I(e) Unspecified and other specified leukemias|75211310|2000
0-14|15.7|17.8|16.7|944|II Lymphomas and reticuloendothelial neoplasms|56294656|2000
0-19|23.9|26.1|25.0|1881|II Lymphomas and reticuloendothelial neoplasms|75211310|2000
0-14|5.3|6.6|5.9|335|II(a) Hodgkin lymphomas|56294656|2000
0-19|11.6|13.2|12.3|930|II(a) Hodgkin lymphomas|75211310|2000
0-14|5.4|6.7|6.0|338|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56294656|2000
0-19|7.6|8.9|8.2|618|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|75211310|2000
0-14|2.4|3.3|2.9|162|II(c) Burkitt lymphoma|56294656|2000
0-19|2.4|3.1|2.7|207|II(c) Burkitt lymphoma|75211310|2000
0-14|1.0|1.6|1.3|73|II(d) Miscellaneous lymphoreticular neoplasms|56294656|2000
0-19|0.8|1.3|1.0|76|II(d) Miscellaneous lymphoreticular neoplasms|75211310|2000
0-14|0.4|0.9|0.6|36|II(e) Unspecified lymphomas|56294656|2000
0-19|0.5|0.9|0.7|50|II(e) Unspecified lymphomas|75211310|2000
0-14|31.7|34.8|33.2|1868|III CNS and misc intracranial and intraspinal neoplasms|56294656|2000
0-19|29.1|31.6|30.4|2281|III CNS and misc intracranial and intraspinal neoplasms|75211310|2000
0-14|2.3|3.2|2.7|153|III(a) Ependymomas and choroid plexus tumor|56294656|2000
0-19|2.0|2.8|2.4|178|III(a) Ependymomas and choroid plexus tumor|75211310|2000
0-14|16.1|18.2|17.1|963|III(b) Astrocytomas|56294656|2000
0-19|14.9|16.7|15.8|1189|III(b) Astrocytomas|75211310|2000
0-14|6.9|8.4|7.6|429|III(c) Intracranial and intraspinal embryonal tumors|56294656|2000
0-19|6.0|7.2|6.6|493|III(c) Intracranial and intraspinal embryonal tumors|75211310|2000
0-14|4.1|5.2|4.6|259|III(d) Other gliomas|56294656|2000
0-19|4.0|5.0|4.5|338|III(d) Other gliomas|75211310|2000
0-14|0.3|0.6|0.4|24|III(e) Other specified intracranial & intraspinal neoplasms|56294656|2000
0-19|0.3|0.6|0.4|33|III(e) Other specified intracranial & intraspinal neoplasms|75211310|2000
0-14|0.5|1.0|0.7|40|III(f) Unspecified intracranial and intraspinal neoplasms|56294656|2000
0-19|0.5|0.9|0.7|50|III(f) Unspecified intracranial and intraspinal neoplasms|75211310|2000
0-14|9.2|10.8|10.0|557|IV Neuroblastoma and other peripheral nervous cell tumors|56294656|2000
0-19|7.0|8.2|7.6|566|IV Neuroblastoma and other peripheral nervous cell tumors|75211310|2000
0-14|9.0|10.7|9.9|550|IV(a) Neuroblastoma and ganglioneuroblastoma|56294656|2000
0-19|6.9|8.1|7.5|557|IV(a) Neuroblastoma and ganglioneuroblastoma|75211310|2000
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|56294656|2000
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|75211310|2000
0-14|9.7|11.4|10.5|592|IX Soft tissue and other extraosseous sarcomas|56294656|2000
0-19|11.3|12.8|12.0|904|IX Soft tissue and other extraosseous sarcomas|75211310|2000
0-14|4.7|5.9|5.3|297|IX(a) Rhabdomyosarcomas|56294656|2000
0-19|4.4|5.4|4.9|369|IX(a) Rhabdomyosarcomas|75211310|2000
0-14|0.7|1.2|0.9|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56294656|2000
0-19|1.0|1.5|1.2|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|75211310|2000
0-14|~|~|~|~|IX(c) Kaposi sarcoma|56294656|2000
0-19|~|~|~|~|IX(c) Kaposi sarcoma|75211310|2000
0-14|2.7|3.7|3.2|180|IX(d) Other specified soft tissue sarcomas|56294656|2000
0-19|4.0|5.0|4.5|336|IX(d) Other specified soft tissue sarcomas|75211310|2000
0-14|0.8|1.4|1.1|61|IX(e) Unspecified soft tissue sarcomas|56294656|2000
0-19|1.1|1.7|1.4|105|IX(e) Unspecified soft tissue sarcomas|75211310|2000
0-14|~|~|~|~|Not classified by ICCC|56294656|2000
0-19|0.1|0.3|0.2|16|Not classified by ICCC|75211310|2000
0-14|3.9|5.0|4.4|245|V Retinoblastoma|56294656|2000
0-19|2.9|3.7|3.3|246|V Retinoblastoma|75211310|2000
0-14|8.0|9.5|8.7|488|VI Renal tumors|56294656|2000
0-19|6.2|7.4|6.8|509|VI Renal tumors|75211310|2000
0-14|7.6|9.1|8.3|465|VI(a) Nephroblastoma and other nonepithelial renal tumors|56294656|2000
0-19|5.7|6.9|6.3|470|VI(a) Nephroblastoma and other nonepithelial renal tumors|75211310|2000
0-14|0.2|0.6|0.4|22|VI(b) Renal carcinomas|56294656|2000
0-19|0.3|0.7|0.5|37|VI(b) Renal carcinomas|75211310|2000
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|56294656|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|75211310|2000
0-14|1.8|2.6|2.2|123|VII Hepatic tumors|56294656|2000
0-19|1.5|2.2|1.8|137|VII Hepatic tumors|75211310|2000
0-14|1.6|2.4|2.0|110|VII(a) Hepatoblastoma|56294656|2000
0-19|1.2|1.8|1.5|110|VII(a) Hepatoblastoma|75211310|2000
0-14|~|~|~|~|VII(b) Hepatic carcinomas|56294656|2000
0-19|0.2|0.5|0.4|27|VII(b) Hepatic carcinomas|75211310|2000
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56294656|2000
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|75211310|2000
0-14|5.9|7.3|6.6|373|VIII Malignant bone tumors|56294656|2000
0-19|7.8|9.2|8.5|639|VIII Malignant bone tumors|75211310|2000
0-14|3.1|4.1|3.6|203|VIII(a) Osteosarcomas|56294656|2000
0-19|4.3|5.3|4.8|359|VIII(a) Osteosarcomas|75211310|2000
0-14|~|~|~|~|VIII(b) Chondrosarcomas|56294656|2000
0-19|~|~|~|~|VIII(b) Chondrosarcomas|75211310|2000
0-14|2.3|3.1|2.7|151|VIII(c) Ewing tumor and related sarcomas of bone|56294656|2000
0-19|2.7|3.5|3.1|233|VIII(c) Ewing tumor and related sarcomas of bone|75211310|2000
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|56294656|2000
0-19|0.1|0.4|0.2|18|VIII(d) Other specified malignant bone tumors|75211310|2000
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|56294656|2000
0-19|0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|75211310|2000
0-14|4.4|5.5|4.9|277|X Germ cell, trophoblastic tumors & neoplasms of gonads|56294656|2000
0-19|10.0|11.5|10.7|807|X Germ cell, trophoblastic tumors & neoplasms of gonads|75211310|2000
0-14|1.2|1.8|1.5|82|X(a) Intracranial & intraspinal germ cell tumors|56294656|2000
0-19|1.4|2.0|1.7|125|X(a) Intracranial & intraspinal germ cell tumors|75211310|2000
0-14|0.8|1.4|1.1|61|X(b) Malignant extracranial & extragonadal germ cell tumors|56294656|2000
0-19|1.1|1.7|1.4|104|X(b) Malignant extracranial & extragonadal germ cell tumors|75211310|2000
0-14|1.8|2.6|2.2|124|X(c) Malignant gonadal germ cell tumors|56294656|2000
0-19|6.4|7.7|7.0|529|X(c) Malignant gonadal germ cell tumors|75211310|2000
0-14|~|~|~|~|X(d) Gonadal carcinomas|56294656|2000
0-19|0.3|0.6|0.4|33|X(d) Gonadal carcinomas|75211310|2000
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56294656|2000
0-19|0.1|0.3|0.2|16|X(e) Other and unspecified malignant gonadal tumors|75211310|2000
0-14|5.0|6.3|5.6|319|XI Other malignant epithelial neoplasms and malignant melanomas|56294656|2000
0-19|14.7|16.5|15.6|1174|XI Other malignant epithelial neoplasms and malignant melanomas|75211310|2000
0-14|0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|56294656|2000
0-19|0.2|0.5|0.3|24|XI(a) Adrenocortical carcinomas|75211310|2000
0-14|1.5|2.2|1.8|103|XI(b) Thyroid carcinomas|56294656|2000
0-19|5.1|6.2|5.7|426|XI(b) Thyroid carcinomas|75211310|2000
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|56294656|2000
0-19|0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|75211310|2000
0-14|1.4|2.1|1.7|96|XI(d) Malignant melanomas|56294656|2000
0-19|4.6|5.6|5.1|384|XI(d) Malignant melanomas|75211310|2000
0-14|~|~|~|~|XI(e) Skin carcinomas|56294656|2000
0-19|~|~|~|~|XI(e) Skin carcinomas|75211310|2000
0-14|1.1|1.8|1.4|81|XI(f) Other and unspecified carcinomas|56294656|2000
0-19|3.5|4.4|3.9|294|XI(f) Other and unspecified carcinomas|75211310|2000
0-14|0.6|1.1|0.8|44|XII Other and unspecified malignant neoplasms|56294656|2000
0-19|0.7|1.1|0.9|65|XII Other and unspecified malignant neoplasms|75211310|2000
0-14|~|~|~|~|XII(a) Other specified malignant tumors|56294656|2000
0-19|~|~|~|~|XII(a) Other specified malignant tumors|75211310|2000
0-14|0.4|0.8|0.6|31|XII(b) Other unspecified malignant tumors|56294656|2000
0-19|0.5|0.9|0.7|50|XII(b) Other unspecified malignant tumors|75211310|2000
0-14|153.8|160.3|157.0|8970|All ICCC Groups Combined|57180220|2001
0-19|168.4|174.3|171.3|13107|All ICCC Groups Combined|76516063|2001
0-14|49.1|52.9|51.0|2898|I Leukemias, myeloproliferative & myelodysplastic diseases|57180220|2001
0-19|44.5|47.5|46.0|3500|I Leukemias, myeloproliferative & myelodysplastic diseases|76516063|2001
0-14|37.5|40.7|39.1|2215|I(a) Lymphoid leukemias|57180220|2001
0-19|32.0|34.6|33.2|2523|I(a) Lymphoid leukemias|76516063|2001
0-14|6.7|8.1|7.4|423|I(b) Acute myeloid leukemias|57180220|2001
0-19|7.1|8.4|7.7|591|I(b) Acute myeloid leukemias|76516063|2001
0-14|1.3|2.0|1.6|95|I(c) Chronic myeloproliferative diseases|57180220|2001
0-19|1.9|2.6|2.2|171|I(c) Chronic myeloproliferative diseases|76516063|2001
0-14|1.3|2.0|1.7|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57180220|2001
0-19|1.3|1.8|1.5|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76516063|2001
0-14|1.0|1.6|1.2|70|I(e) Unspecified and other specified leukemias|57180220|2001
0-19|1.0|1.6|1.3|98|I(e) Unspecified and other specified leukemias|76516063|2001
0-14|15.1|17.2|16.1|925|II Lymphomas and reticuloendothelial neoplasms|57180220|2001
0-19|23.6|25.9|24.7|1899|II Lymphomas and reticuloendothelial neoplasms|76516063|2001
0-14|5.3|6.5|5.9|339|II(a) Hodgkin lymphomas|57180220|2001
0-19|11.8|13.4|12.5|965|II(a) Hodgkin lymphomas|76516063|2001
0-14|5.9|7.2|6.5|376|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57180220|2001
0-19|8.1|9.4|8.8|672|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76516063|2001
0-14|1.9|2.7|2.2|128|II(c) Burkitt lymphoma|57180220|2001
0-19|1.8|2.5|2.1|164|II(c) Burkitt lymphoma|76516063|2001
0-14|0.8|1.3|1.0|58|II(d) Miscellaneous lymphoreticular neoplasms|57180220|2001
0-19|0.6|1.0|0.8|60|II(d) Miscellaneous lymphoreticular neoplasms|76516063|2001
0-14|0.3|0.6|0.4|24|II(e) Unspecified lymphomas|57180220|2001
0-19|0.4|0.7|0.5|38|II(e) Unspecified lymphomas|76516063|2001
0-14|31.4|34.4|32.8|1873|III CNS and misc intracranial and intraspinal neoplasms|57180220|2001
0-19|28.8|31.3|30.1|2294|III CNS and misc intracranial and intraspinal neoplasms|76516063|2001
0-14|2.4|3.2|2.8|158|III(a) Ependymomas and choroid plexus tumor|57180220|2001
0-19|2.1|2.8|2.5|187|III(a) Ependymomas and choroid plexus tumor|76516063|2001
0-14|15.3|17.4|16.3|930|III(b) Astrocytomas|57180220|2001
0-19|14.2|15.9|15.0|1148|III(b) Astrocytomas|76516063|2001
0-14|6.6|8.0|7.3|415|III(c) Intracranial and intraspinal embryonal tumors|57180220|2001
0-19|6.0|7.2|6.6|500|III(c) Intracranial and intraspinal embryonal tumors|76516063|2001
0-14|4.9|6.1|5.4|311|III(d) Other gliomas|57180220|2001
0-19|4.5|5.6|5.0|385|III(d) Other gliomas|76516063|2001
0-14|0.5|0.9|0.7|38|III(e) Other specified intracranial & intraspinal neoplasms|57180220|2001
0-19|0.4|0.8|0.6|45|III(e) Other specified intracranial & intraspinal neoplasms|76516063|2001
0-14|0.2|0.6|0.4|21|III(f) Unspecified intracranial and intraspinal neoplasms|57180220|2001
0-19|0.3|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|76516063|2001
0-14|10.9|12.7|11.8|675|IV Neuroblastoma and other peripheral nervous cell tumors|57180220|2001
0-19|8.4|9.7|9.0|690|IV Neuroblastoma and other peripheral nervous cell tumors|76516063|2001
0-14|10.8|12.6|11.7|668|IV(a) Neuroblastoma and ganglioneuroblastoma|57180220|2001
0-19|8.2|9.5|8.8|676|IV(a) Neuroblastoma and ganglioneuroblastoma|76516063|2001
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|57180220|2001
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|76516063|2001
0-14|9.6|11.3|10.5|600|IX Soft tissue and other extraosseous sarcomas|57180220|2001
0-19|11.1|12.7|11.9|911|IX Soft tissue and other extraosseous sarcomas|76516063|2001
0-14|4.6|5.8|5.2|293|IX(a) Rhabdomyosarcomas|57180220|2001
0-19|4.5|5.5|5.0|378|IX(a) Rhabdomyosarcomas|76516063|2001
0-14|1.0|1.6|1.3|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57180220|2001
0-19|1.2|1.7|1.5|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76516063|2001
0-14|~|~|~|~|IX(c) Kaposi sarcoma|57180220|2001
0-19|~|~|~|~|IX(c) Kaposi sarcoma|76516063|2001
0-14|2.6|3.6|3.1|177|IX(d) Other specified soft tissue sarcomas|57180220|2001
0-19|3.7|4.7|4.2|321|IX(d) Other specified soft tissue sarcomas|76516063|2001
0-14|0.7|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|57180220|2001
0-19|1.0|1.5|1.3|97|IX(e) Unspecified soft tissue sarcomas|76516063|2001
0-14|~|~|~|~|Not classified by ICCC|57180220|2001
0-19|0.2|0.4|0.3|22|Not classified by ICCC|76516063|2001
0-14|3.9|5.0|4.5|256|V Retinoblastoma|57180220|2001
0-19|2.9|3.8|3.3|256|V Retinoblastoma|76516063|2001
0-14|7.9|9.4|8.6|488|VI Renal tumors|57180220|2001
0-19|6.2|7.4|6.8|515|VI Renal tumors|76516063|2001
0-14|7.5|9.0|8.2|467|VI(a) Nephroblastoma and other nonepithelial renal tumors|57180220|2001
0-19|5.7|6.8|6.2|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|76516063|2001
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|57180220|2001
0-19|0.4|0.7|0.5|41|VI(b) Renal carcinomas|76516063|2001
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|57180220|2001
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|76516063|2001
0-14|1.7|2.5|2.1|119|VII Hepatic tumors|57180220|2001
0-19|1.5|2.1|1.8|138|VII Hepatic tumors|76516063|2001
0-14|1.4|2.0|1.7|96|VII(a) Hepatoblastoma|57180220|2001
0-19|1.0|1.5|1.3|97|VII(a) Hepatoblastoma|76516063|2001
0-14|0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|57180220|2001
0-19|0.4|0.7|0.5|40|VII(b) Hepatic carcinomas|76516063|2001
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57180220|2001
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76516063|2001
0-14|6.2|7.6|6.9|397|VIII Malignant bone tumors|57180220|2001
0-19|8.8|10.2|9.5|731|VIII Malignant bone tumors|76516063|2001
0-14|3.3|4.3|3.7|216|VIII(a) Osteosarcomas|57180220|2001
0-19|4.7|5.7|5.2|398|VIII(a) Osteosarcomas|76516063|2001
0-14|~|~|~|~|VIII(b) Chondrosarcomas|57180220|2001
0-19|0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|76516063|2001
0-14|2.3|3.1|2.7|154|VIII(c) Ewing tumor and related sarcomas of bone|57180220|2001
0-19|3.0|3.8|3.4|262|VIII(c) Ewing tumor and related sarcomas of bone|76516063|2001
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|57180220|2001
0-19|0.3|0.6|0.4|32|VIII(d) Other specified malignant bone tumors|76516063|2001
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|57180220|2001
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|76516063|2001
0-14|4.5|5.7|5.1|293|X Germ cell, trophoblastic tumors & neoplasms of gonads|57180220|2001
0-19|9.8|11.2|10.5|807|X Germ cell, trophoblastic tumors & neoplasms of gonads|76516063|2001
0-14|1.0|1.6|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|57180220|2001
0-19|1.3|1.9|1.6|123|X(a) Intracranial & intraspinal germ cell tumors|76516063|2001
0-14|1.1|1.7|1.4|81|X(b) Malignant extracranial & extragonadal germ cell tumors|57180220|2001
0-19|1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|76516063|2001
0-14|1.7|2.5|2.1|120|X(c) Malignant gonadal germ cell tumors|57180220|2001
0-19|6.1|7.3|6.7|512|X(c) Malignant gonadal germ cell tumors|76516063|2001
0-14|~|~|~|~|X(d) Gonadal carcinomas|57180220|2001
0-19|0.2|0.5|0.3|26|X(d) Gonadal carcinomas|76516063|2001
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57180220|2001
0-19|0.2|0.4|0.3|23|X(e) Other and unspecified malignant gonadal tumors|76516063|2001
0-14|6.1|7.5|6.8|391|XI Other malignant epithelial neoplasms and malignant melanomas|57180220|2001
0-19|15.7|17.5|16.6|1278|XI Other malignant epithelial neoplasms and malignant melanomas|76516063|2001
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|57180220|2001
0-19|0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|76516063|2001
0-14|2.0|2.8|2.3|136|XI(b) Thyroid carcinomas|57180220|2001
0-19|5.3|6.4|5.8|447|XI(b) Thyroid carcinomas|76516063|2001
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|57180220|2001
0-19|0.4|0.8|0.6|44|XI(c) Nasopharyngeal carcinomas|76516063|2001
0-14|1.7|2.5|2.1|119|XI(d) Malignant melanomas|57180220|2001
0-19|5.3|6.4|5.9|452|XI(d) Malignant melanomas|76516063|2001
0-14|~|~|~|~|XI(e) Skin carcinomas|57180220|2001
0-19|~|~|~|~|XI(e) Skin carcinomas|76516063|2001
0-14|1.4|2.1|1.7|99|XI(f) Other and unspecified carcinomas|57180220|2001
0-19|3.6|4.6|4.1|314|XI(f) Other and unspecified carcinomas|76516063|2001
0-14|0.5|1.0|0.7|40|XII Other and unspecified malignant neoplasms|57180220|2001
0-19|0.7|1.1|0.9|66|XII Other and unspecified malignant neoplasms|76516063|2001
0-14|0.2|0.6|0.4|21|XII(a) Other specified malignant tumors|57180220|2001
0-19|0.3|0.5|0.4|29|XII(a) Other specified malignant tumors|76516063|2001
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|57180220|2001
0-19|0.3|0.7|0.5|37|XII(b) Other unspecified malignant tumors|76516063|2001
0-14|152.7|159.2|155.9|8915|All ICCC Groups Combined|57184152|2002
0-19|168.3|174.2|171.3|13131|All ICCC Groups Combined|76630713|2002
0-14|47.9|51.6|49.7|2831|I Leukemias, myeloproliferative & myelodysplastic diseases|57184152|2002
0-19|43.6|46.7|45.1|3442|I Leukemias, myeloproliferative & myelodysplastic diseases|76630713|2002
0-14|35.7|38.9|37.3|2118|I(a) Lymphoid leukemias|57184152|2002
0-19|30.8|33.3|32.0|2437|I(a) Lymphoid leukemias|76630713|2002
0-14|7.2|8.7|7.9|456|I(b) Acute myeloid leukemias|57184152|2002
0-19|7.6|8.9|8.3|636|I(b) Acute myeloid leukemias|76630713|2002
0-14|1.3|2.0|1.6|92|I(c) Chronic myeloproliferative diseases|57184152|2002
0-19|1.8|2.5|2.1|163|I(c) Chronic myeloproliferative diseases|76630713|2002
0-14|1.3|2.0|1.6|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57184152|2002
0-19|1.2|1.8|1.5|116|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76630713|2002
0-14|1.0|1.6|1.3|73|I(e) Unspecified and other specified leukemias|57184152|2002
0-19|0.9|1.4|1.2|90|I(e) Unspecified and other specified leukemias|76630713|2002
0-14|14.6|16.7|15.6|901|II Lymphomas and reticuloendothelial neoplasms|57184152|2002
0-19|23.3|25.5|24.3|1878|II Lymphomas and reticuloendothelial neoplasms|76630713|2002
0-14|4.8|6.0|5.4|312|II(a) Hodgkin lymphomas|57184152|2002
0-19|11.4|12.9|12.1|940|II(a) Hodgkin lymphomas|76630713|2002
0-14|5.5|6.8|6.2|354|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57184152|2002
0-19|7.6|8.9|8.3|637|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76630713|2002
0-14|2.3|3.2|2.8|157|II(c) Burkitt lymphoma|57184152|2002
0-19|2.4|3.1|2.7|208|II(c) Burkitt lymphoma|76630713|2002
0-14|0.9|1.5|1.2|66|II(d) Miscellaneous lymphoreticular neoplasms|57184152|2002
0-19|0.7|1.1|0.9|67|II(d) Miscellaneous lymphoreticular neoplasms|76630713|2002
0-14|~|~|~|~|II(e) Unspecified lymphomas|57184152|2002
0-19|0.2|0.5|0.3|26|II(e) Unspecified lymphomas|76630713|2002
0-14|33.1|36.2|34.7|1974|III CNS and misc intracranial and intraspinal neoplasms|57184152|2002
0-19|30.2|32.7|31.4|2400|III CNS and misc intracranial and intraspinal neoplasms|76630713|2002
0-14|3.2|4.2|3.6|208|III(a) Ependymomas and choroid plexus tumor|57184152|2002
0-19|2.6|3.4|3.0|228|III(a) Ependymomas and choroid plexus tumor|76630713|2002
0-14|15.4|17.5|16.4|936|III(b) Astrocytomas|57184152|2002
0-19|14.5|16.2|15.3|1172|III(b) Astrocytomas|76630713|2002
0-14|6.8|8.2|7.5|425|III(c) Intracranial and intraspinal embryonal tumors|57184152|2002
0-19|5.9|7.0|6.4|488|III(c) Intracranial and intraspinal embryonal tumors|76630713|2002
0-14|5.4|6.7|6.0|340|III(d) Other gliomas|57184152|2002
0-19|5.1|6.1|5.6|426|III(d) Other gliomas|76630713|2002
0-14|0.5|1.0|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|57184152|2002
0-19|0.6|0.9|0.7|56|III(e) Other specified intracranial & intraspinal neoplasms|76630713|2002
0-14|0.3|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|57184152|2002
0-19|0.3|0.6|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|76630713|2002
0-14|10.1|11.9|11.0|627|IV Neuroblastoma and other peripheral nervous cell tumors|57184152|2002
0-19|7.8|9.1|8.4|643|IV Neuroblastoma and other peripheral nervous cell tumors|76630713|2002
0-14|10.0|11.7|10.9|620|IV(a) Neuroblastoma and ganglioneuroblastoma|57184152|2002
0-19|7.6|8.9|8.2|625|IV(a) Neuroblastoma and ganglioneuroblastoma|76630713|2002
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|57184152|2002
0-19|0.1|0.4|0.2|18|IV(b) Other peripheral nervous cell tumors|76630713|2002
0-14|10.2|11.9|11.0|631|IX Soft tissue and other extraosseous sarcomas|57184152|2002
0-19|11.1|12.7|11.9|913|IX Soft tissue and other extraosseous sarcomas|76630713|2002
0-14|4.9|6.1|5.5|311|IX(a) Rhabdomyosarcomas|57184152|2002
0-19|4.4|5.5|4.9|376|IX(a) Rhabdomyosarcomas|76630713|2002
0-14|0.9|1.5|1.2|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57184152|2002
0-19|1.0|1.5|1.2|93|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76630713|2002
0-14|~|~|~|~|IX(c) Kaposi sarcoma|57184152|2002
0-19|~|~|~|~|IX(c) Kaposi sarcoma|76630713|2002
0-14|3.0|3.9|3.4|197|IX(d) Other specified soft tissue sarcomas|57184152|2002
0-19|4.3|5.3|4.8|367|IX(d) Other specified soft tissue sarcomas|76630713|2002
0-14|0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|57184152|2002
0-19|0.8|1.2|1.0|77|IX(e) Unspecified soft tissue sarcomas|76630713|2002
0-14|0.2|0.5|0.3|19|Not classified by ICCC|57184152|2002
0-19|0.2|0.5|0.3|24|Not classified by ICCC|76630713|2002
0-14|3.3|4.3|3.7|214|V Retinoblastoma|57184152|2002
0-19|2.4|3.2|2.8|214|V Retinoblastoma|76630713|2002
0-14|7.5|9.0|8.2|468|VI Renal tumors|57184152|2002
0-19|5.9|7.1|6.5|492|VI Renal tumors|76630713|2002
0-14|7.3|8.8|8.0|455|VI(a) Nephroblastoma and other nonepithelial renal tumors|57184152|2002
0-19|5.5|6.6|6.0|458|VI(a) Nephroblastoma and other nonepithelial renal tumors|76630713|2002
0-14|~|~|~|~|VI(b) Renal carcinomas|57184152|2002
0-19|0.3|0.6|0.4|33|VI(b) Renal carcinomas|76630713|2002
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|57184152|2002
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|76630713|2002
0-14|1.6|2.3|1.9|111|VII Hepatic tumors|57184152|2002
0-19|1.4|2.0|1.7|130|VII Hepatic tumors|76630713|2002
0-14|1.3|1.9|1.6|90|VII(a) Hepatoblastoma|57184152|2002
0-19|1.0|1.5|1.2|91|VII(a) Hepatoblastoma|76630713|2002
0-14|0.2|0.5|0.3|20|VII(b) Hepatic carcinomas|57184152|2002
0-19|0.3|0.7|0.5|38|VII(b) Hepatic carcinomas|76630713|2002
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57184152|2002
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76630713|2002
0-14|6.4|7.8|7.0|407|VIII Malignant bone tumors|57184152|2002
0-19|8.6|10.0|9.3|715|VIII Malignant bone tumors|76630713|2002
0-14|3.3|4.3|3.8|219|VIII(a) Osteosarcomas|57184152|2002
0-19|4.5|5.5|5.0|384|VIII(a) Osteosarcomas|76630713|2002
0-14|~|~|~|~|VIII(b) Chondrosarcomas|57184152|2002
0-19|0.3|0.7|0.5|37|VIII(b) Chondrosarcomas|76630713|2002
0-14|2.2|3.1|2.6|151|VIII(c) Ewing tumor and related sarcomas of bone|57184152|2002
0-19|2.7|3.5|3.1|240|VIII(c) Ewing tumor and related sarcomas of bone|76630713|2002
0-14|0.2|0.6|0.4|21|VIII(d) Other specified malignant bone tumors|57184152|2002
0-19|0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|76630713|2002
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|57184152|2002
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|76630713|2002
0-14|4.8|6.0|5.4|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|57184152|2002
0-19|10.4|11.9|11.2|863|X Germ cell, trophoblastic tumors & neoplasms of gonads|76630713|2002
0-14|1.2|1.8|1.5|85|X(a) Intracranial & intraspinal germ cell tumors|57184152|2002
0-19|1.4|2.0|1.7|130|X(a) Intracranial & intraspinal germ cell tumors|76630713|2002
0-14|1.2|1.9|1.5|87|X(b) Malignant extracranial & extragonadal germ cell tumors|57184152|2002
0-19|1.3|1.9|1.6|124|X(b) Malignant extracranial & extragonadal germ cell tumors|76630713|2002
0-14|1.9|2.7|2.2|130|X(c) Malignant gonadal germ cell tumors|57184152|2002
0-19|6.7|7.9|7.3|561|X(c) Malignant gonadal germ cell tumors|76630713|2002
0-14|~|~|~|~|X(d) Gonadal carcinomas|57184152|2002
0-19|0.2|0.5|0.3|25|X(d) Gonadal carcinomas|76630713|2002
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57184152|2002
0-19|0.2|0.4|0.3|23|X(e) Other and unspecified malignant gonadal tumors|76630713|2002
0-14|5.9|7.3|6.6|383|XI Other malignant epithelial neoplasms and malignant melanomas|57184152|2002
0-19|16.5|18.3|17.4|1346|XI Other malignant epithelial neoplasms and malignant melanomas|76630713|2002
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|57184152|2002
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|76630713|2002
0-14|1.6|2.4|2.0|115|XI(b) Thyroid carcinomas|57184152|2002
0-19|5.2|6.3|5.7|443|XI(b) Thyroid carcinomas|76630713|2002
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|57184152|2002
0-19|0.5|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|76630713|2002
0-14|2.0|2.8|2.4|136|XI(d) Malignant melanomas|57184152|2002
0-19|6.1|7.3|6.7|515|XI(d) Malignant melanomas|76630713|2002
0-14|~|~|~|~|XI(e) Skin carcinomas|57184152|2002
0-19|~|~|~|~|XI(e) Skin carcinomas|76630713|2002
0-14|1.4|2.0|1.7|98|XI(f) Other and unspecified carcinomas|57184152|2002
0-19|3.6|4.5|4.0|312|XI(f) Other and unspecified carcinomas|76630713|2002
0-14|0.5|0.9|0.6|37|XII Other and unspecified malignant neoplasms|57184152|2002
0-19|0.7|1.2|0.9|71|XII Other and unspecified malignant neoplasms|76630713|2002
0-14|0.2|0.6|0.4|21|XII(a) Other specified malignant tumors|57184152|2002
0-19|0.3|0.6|0.5|36|XII(a) Other specified malignant tumors|76630713|2002
0-14|0.2|0.5|0.3|16|XII(b) Other unspecified malignant tumors|57184152|2002
0-19|0.3|0.6|0.5|35|XII(b) Other unspecified malignant tumors|76630713|2002
0-14|148.8|155.0|151.9|9230|All ICCC Groups Combined|60628650|2003
0-19|164.4|170.0|167.2|13652|All ICCC Groups Combined|81425816|2003
0-14|45.9|49.4|47.6|2878|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|2003
0-19|41.9|44.8|43.3|3515|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|2003
0-14|34.5|37.5|36.0|2168|I(a) Lymphoid leukemias|60628650|2003
0-19|29.5|32.0|30.7|2482|I(a) Lymphoid leukemias|81425816|2003
0-14|6.8|8.2|7.5|455|I(b) Acute myeloid leukemias|60628650|2003
0-19|7.2|8.4|7.8|636|I(b) Acute myeloid leukemias|81425816|2003
0-14|1.2|1.8|1.4|88|I(c) Chronic myeloproliferative diseases|60628650|2003
0-19|1.9|2.5|2.2|181|I(c) Chronic myeloproliferative diseases|81425816|2003
0-14|1.5|2.2|1.8|109|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|2003
0-19|1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|2003
0-14|0.7|1.2|1.0|58|I(e) Unspecified and other specified leukemias|60628650|2003
0-19|0.8|1.2|1.0|82|I(e) Unspecified and other specified leukemias|81425816|2003
0-14|15.1|17.2|16.1|983|II Lymphomas and reticuloendothelial neoplasms|60628650|2003
0-19|23.1|25.3|24.2|1984|II Lymphomas and reticuloendothelial neoplasms|81425816|2003
0-14|5.3|6.5|5.9|362|II(a) Hodgkin lymphomas|60628650|2003
0-19|11.7|13.2|12.4|1025|II(a) Hodgkin lymphomas|81425816|2003
0-14|5.7|7.0|6.3|383|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|2003
0-19|7.5|8.7|8.1|659|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|2003
0-14|2.3|3.1|2.7|162|II(c) Burkitt lymphoma|60628650|2003
0-19|2.3|3.0|2.6|211|II(c) Burkitt lymphoma|81425816|2003
0-14|0.9|1.4|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|60628650|2003
0-19|0.7|1.1|0.9|72|II(d) Miscellaneous lymphoreticular neoplasms|81425816|2003
0-14|~|~|~|~|II(e) Unspecified lymphomas|60628650|2003
0-19|0.1|0.3|0.2|17|II(e) Unspecified lymphomas|81425816|2003
0-14|31.3|34.2|32.7|1981|III CNS and misc intracranial and intraspinal neoplasms|60628650|2003
0-19|28.8|31.2|30.0|2435|III CNS and misc intracranial and intraspinal neoplasms|81425816|2003
0-14|2.1|2.9|2.5|152|III(a) Ependymomas and choroid plexus tumor|60628650|2003
0-19|2.0|2.7|2.3|189|III(a) Ependymomas and choroid plexus tumor|81425816|2003
0-14|15.3|17.3|16.3|987|III(b) Astrocytomas|60628650|2003
0-19|14.4|16.1|15.2|1238|III(b) Astrocytomas|81425816|2003
0-14|6.6|7.9|7.2|435|III(c) Intracranial and intraspinal embryonal tumors|60628650|2003
0-19|5.6|6.7|6.1|495|III(c) Intracranial and intraspinal embryonal tumors|81425816|2003
0-14|5.0|6.2|5.6|336|III(d) Other gliomas|60628650|2003
0-19|4.7|5.7|5.2|419|III(d) Other gliomas|81425816|2003
0-14|0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|60628650|2003
0-19|0.6|1.0|0.8|65|III(e) Other specified intracranial & intraspinal neoplasms|81425816|2003
0-14|0.2|0.5|0.3|20|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|2003
0-19|0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|2003
0-14|9.9|11.5|10.7|651|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|2003
0-19|7.6|8.8|8.2|666|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|2003
0-14|9.7|11.4|10.5|642|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|2003
0-19|7.4|8.7|8.0|653|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|2003
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|2003
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|2003
0-14|9.7|11.4|10.5|642|IX Soft tissue and other extraosseous sarcomas|60628650|2003
0-19|11.3|12.8|12.1|988|IX Soft tissue and other extraosseous sarcomas|81425816|2003
0-14|4.5|5.7|5.1|307|IX(a) Rhabdomyosarcomas|60628650|2003
0-19|4.3|5.3|4.8|390|IX(a) Rhabdomyosarcomas|81425816|2003
0-14|0.8|1.3|1.0|61|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|2003
0-19|1.2|1.7|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|2003
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60628650|2003
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81425816|2003
0-14|3.0|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60628650|2003
0-19|4.2|5.1|4.6|379|IX(d) Other specified soft tissue sarcomas|81425816|2003
0-14|0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|2003
0-19|1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81425816|2003
0-14|0.2|0.4|0.3|16|Not classified by ICCC|60628650|2003
0-19|0.2|0.4|0.3|22|Not classified by ICCC|81425816|2003
0-14|3.6|4.6|4.1|248|V Retinoblastoma|60628650|2003
0-19|2.7|3.5|3.1|249|V Retinoblastoma|81425816|2003
0-14|7.8|9.3|8.5|516|VI Renal tumors|60628650|2003
0-19|6.2|7.3|6.7|543|VI Renal tumors|81425816|2003
0-14|7.4|8.9|8.1|491|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|2003
0-19|5.6|6.7|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|2003
0-14|0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|2003
0-19|0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|2003
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|2003
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|2003
0-14|2.1|2.9|2.5|151|VII Hepatic tumors|60628650|2003
0-19|1.8|2.5|2.1|173|VII Hepatic tumors|81425816|2003
0-14|1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|2003
0-19|1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|2003
0-14|0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60628650|2003
0-19|0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81425816|2003
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|2003
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|2003
0-14|6.0|7.3|6.7|410|VIII Malignant bone tumors|60628650|2003
0-19|8.1|9.3|8.7|716|VIII Malignant bone tumors|81425816|2003
0-14|3.2|4.2|3.7|229|VIII(a) Osteosarcomas|60628650|2003
0-19|4.8|5.8|5.3|439|VIII(a) Osteosarcomas|81425816|2003
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60628650|2003
0-19|0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|2003
0-14|1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|2003
0-19|2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|2003
0-14|0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|2003
0-19|0.2|0.5|0.3|27|VIII(d) Other specified malignant bone tumors|81425816|2003
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|2003
0-19|0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|2003
0-14|4.5|5.7|5.1|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|2003
0-19|9.6|11.0|10.2|846|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|2003
0-14|0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60628650|2003
0-19|1.1|1.6|1.4|113|X(a) Intracranial & intraspinal germ cell tumors|81425816|2003
0-14|1.1|1.8|1.4|87|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|2003
0-19|1.2|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|2003
0-14|1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|2003
0-19|6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|2003
0-14|~|~|~|~|X(d) Gonadal carcinomas|60628650|2003
0-19|0.2|0.5|0.4|30|X(d) Gonadal carcinomas|81425816|2003
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|2003
0-19|0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|81425816|2003
0-14|5.7|7.0|6.4|394|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|2003
0-19|16.4|18.2|17.3|1427|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|2003
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|2003
0-19|0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|81425816|2003
0-14|1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|2003
0-19|5.6|6.7|6.1|506|XI(b) Thyroid carcinomas|81425816|2003
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|2003
0-19|0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|2003
0-14|1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|2003
0-19|5.4|6.4|5.9|488|XI(d) Malignant melanomas|81425816|2003
0-14|~|~|~|~|XI(e) Skin carcinomas|60628650|2003
0-19|~|~|~|~|XI(e) Skin carcinomas|81425816|2003
0-14|1.5|2.2|1.8|113|XI(f) Other and unspecified carcinomas|60628650|2003
0-19|3.8|4.7|4.2|349|XI(f) Other and unspecified carcinomas|81425816|2003
0-14|0.6|1.0|0.8|48|XII Other and unspecified malignant neoplasms|60628650|2003
0-19|0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|81425816|2003
0-14|0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|2003
0-19|0.3|0.6|0.5|39|XII(a) Other specified malignant tumors|81425816|2003
0-14|0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|60628650|2003
0-19|0.4|0.8|0.6|49|XII(b) Other unspecified malignant tumors|81425816|2003
0-14|156.4|162.8|159.6|9719|All ICCC Groups Combined|60651802|2004
0-19|170.8|176.5|173.7|14268|All ICCC Groups Combined|81754354|2004
0-14|49.3|52.9|51.1|3100|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|2004
0-19|44.6|47.6|46.1|3755|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|2004
0-14|37.2|40.4|38.8|2346|I(a) Lymphoid leukemias|60651802|2004
0-19|32.0|34.5|33.2|2696|I(a) Lymphoid leukemias|81754354|2004
0-14|7.2|8.7|7.9|484|I(b) Acute myeloid leukemias|60651802|2004
0-19|7.6|8.8|8.2|674|I(b) Acute myeloid leukemias|81754354|2004
0-14|1.2|1.9|1.5|93|I(c) Chronic myeloproliferative diseases|60651802|2004
0-19|1.8|2.4|2.1|172|I(c) Chronic myeloproliferative diseases|81754354|2004
0-14|1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|2004
0-19|1.1|1.6|1.4|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|2004
0-14|1.1|1.7|1.4|85|I(e) Unspecified and other specified leukemias|60651802|2004
0-19|1.0|1.5|1.2|102|I(e) Unspecified and other specified leukemias|81754354|2004
0-14|15.1|17.1|16.1|984|II Lymphomas and reticuloendothelial neoplasms|60651802|2004
0-19|23.1|25.2|24.1|1996|II Lymphomas and reticuloendothelial neoplasms|81754354|2004
0-14|4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|2004
0-19|11.1|12.6|11.8|986|II(a) Hodgkin lymphomas|81754354|2004
0-14|6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|2004
0-19|7.9|9.2|8.5|704|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|2004
0-14|2.1|2.9|2.5|148|II(c) Burkitt lymphoma|60651802|2004
0-19|2.0|2.7|2.4|192|II(c) Burkitt lymphoma|81754354|2004
0-14|1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|2004
0-19|0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|2004
0-14|~|~|~|~|II(e) Unspecified lymphomas|60651802|2004
0-19|0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|2004
0-14|33.3|36.3|34.8|2106|III CNS and misc intracranial and intraspinal neoplasms|60651802|2004
0-19|30.7|33.1|31.9|2594|III CNS and misc intracranial and intraspinal neoplasms|81754354|2004
0-14|2.5|3.4|2.9|179|III(a) Ependymomas and choroid plexus tumor|60651802|2004
0-19|2.4|3.1|2.7|221|III(a) Ependymomas and choroid plexus tumor|81754354|2004
0-14|16.3|18.4|17.3|1048|III(b) Astrocytomas|60651802|2004
0-19|15.4|17.2|16.3|1327|III(b) Astrocytomas|81754354|2004
0-14|7.1|8.5|7.8|471|III(c) Intracranial and intraspinal embryonal tumors|60651802|2004
0-19|6.0|7.2|6.6|533|III(c) Intracranial and intraspinal embryonal tumors|81754354|2004
0-14|4.8|6.0|5.4|325|III(d) Other gliomas|60651802|2004
0-19|4.6|5.6|5.1|413|III(d) Other gliomas|81754354|2004
0-14|0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|2004
0-19|0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|2004
0-14|0.4|0.8|0.6|34|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|2004
0-19|0.4|0.7|0.5|41|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|2004
0-14|10.2|11.8|11.0|673|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|2004
0-19|7.8|9.1|8.4|691|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|2004
0-14|10.0|11.6|10.8|660|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|2004
0-19|7.6|8.8|8.2|669|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|2004
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|2004
0-19|0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|81754354|2004
0-14|9.8|11.4|10.6|648|IX Soft tissue and other extraosseous sarcomas|60651802|2004
0-19|11.3|12.8|12.1|995|IX Soft tissue and other extraosseous sarcomas|81754354|2004
0-14|4.1|5.3|4.7|284|IX(a) Rhabdomyosarcomas|60651802|2004
0-19|3.9|4.8|4.3|355|IX(a) Rhabdomyosarcomas|81754354|2004
0-14|1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|2004
0-19|1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|2004
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60651802|2004
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81754354|2004
0-14|3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|2004
0-19|4.6|5.6|5.1|423|IX(d) Other specified soft tissue sarcomas|81754354|2004
0-14|0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60651802|2004
0-19|1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81754354|2004
0-14|~|~|~|~|Not classified by ICCC|60651802|2004
0-19|0.2|0.5|0.3|26|Not classified by ICCC|81754354|2004
0-14|3.8|4.9|4.3|266|V Retinoblastoma|60651802|2004
0-19|2.9|3.6|3.2|266|V Retinoblastoma|81754354|2004
0-14|7.4|8.9|8.1|494|VI Renal tumors|60651802|2004
0-19|5.9|7.1|6.5|528|VI Renal tumors|81754354|2004
0-14|7.1|8.5|7.8|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|2004
0-19|5.4|6.5|5.9|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|2004
0-14|0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|2004
0-19|0.4|0.7|0.6|46|VI(b) Renal carcinomas|81754354|2004
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|2004
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|2004
0-14|2.3|3.1|2.7|164|VII Hepatic tumors|60651802|2004
0-19|2.1|2.8|2.4|198|VII Hepatic tumors|81754354|2004
0-14|2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|2004
0-19|1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|2004
0-14|~|~|~|~|VII(b) Hepatic carcinomas|60651802|2004
0-19|0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81754354|2004
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|2004
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|2004
0-14|6.4|7.8|7.1|434|VIII Malignant bone tumors|60651802|2004
0-19|8.3|9.6|9.0|742|VIII Malignant bone tumors|81754354|2004
0-14|3.6|4.6|4.1|252|VIII(a) Osteosarcomas|60651802|2004
0-19|4.6|5.6|5.1|424|VIII(a) Osteosarcomas|81754354|2004
0-14|0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|2004
0-19|0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81754354|2004
0-14|1.9|2.7|2.3|142|VIII(c) Ewing tumor and related sarcomas of bone|60651802|2004
0-19|2.4|3.1|2.7|225|VIII(c) Ewing tumor and related sarcomas of bone|81754354|2004
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|2004
0-19|0.3|0.6|0.5|39|VIII(d) Other specified malignant bone tumors|81754354|2004
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|2004
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|2004
0-14|5.0|6.2|5.6|347|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|2004
0-19|10.4|11.8|11.1|924|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|2004
0-14|1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|2004
0-19|1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|81754354|2004
0-14|1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|2004
0-19|1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|2004
0-14|2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|2004
0-19|6.7|7.9|7.3|607|X(c) Malignant gonadal germ cell tumors|81754354|2004
0-14|~|~|~|~|X(d) Gonadal carcinomas|60651802|2004
0-19|0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|2004
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|2004
0-19|0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|2004
0-14|6.6|8.0|7.3|447|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|2004
0-19|16.9|18.7|17.8|1484|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|2004
0-14|0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|2004
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|2004
0-14|2.2|3.0|2.6|159|XI(b) Thyroid carcinomas|60651802|2004
0-19|6.2|7.3|6.8|564|XI(b) Thyroid carcinomas|81754354|2004
0-14|0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|2004
0-19|0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|2004
0-14|2.1|2.9|2.5|153|XI(d) Malignant melanomas|60651802|2004
0-19|5.9|7.0|6.4|535|XI(d) Malignant melanomas|81754354|2004
0-14|~|~|~|~|XI(e) Skin carcinomas|60651802|2004
0-19|~|~|~|~|XI(e) Skin carcinomas|81754354|2004
0-14|1.2|1.8|1.4|89|XI(f) Other and unspecified carcinomas|60651802|2004
0-19|3.3|4.2|3.7|312|XI(f) Other and unspecified carcinomas|81754354|2004
0-14|0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60651802|2004
0-19|0.6|1.1|0.8|69|XII Other and unspecified malignant neoplasms|81754354|2004
0-14|0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60651802|2004
0-19|0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|81754354|2004
0-14|0.3|0.6|0.4|24|XII(b) Other unspecified malignant tumors|60651802|2004
0-19|0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|81754354|2004
0-14|152.3|158.6|155.4|9456|All ICCC Groups Combined|60519046|2005
0-19|169.0|174.7|171.8|14200|All ICCC Groups Combined|82005260|2005
0-14|47.4|50.9|49.1|2985|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|2005
0-19|43.0|45.9|44.4|3637|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|2005
0-14|35.9|39.0|37.4|2270|I(a) Lymphoid leukemias|60519046|2005
0-19|30.8|33.3|32.0|2613|I(a) Lymphoid leukemias|82005260|2005
0-14|6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|2005
0-19|6.9|8.1|7.5|622|I(b) Acute myeloid leukemias|82005260|2005
0-14|1.1|1.7|1.4|84|I(c) Chronic myeloproliferative diseases|60519046|2005
0-19|1.7|2.3|2.0|164|I(c) Chronic myeloproliferative diseases|82005260|2005
0-14|1.3|2.0|1.6|99|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|2005
0-19|1.3|1.9|1.6|129|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|2005
0-14|1.1|1.8|1.4|87|I(e) Unspecified and other specified leukemias|60519046|2005
0-19|1.1|1.6|1.3|109|I(e) Unspecified and other specified leukemias|82005260|2005
0-14|15.6|17.7|16.6|1012|II Lymphomas and reticuloendothelial neoplasms|60519046|2005
0-19|24.7|26.9|25.8|2151|II Lymphomas and reticuloendothelial neoplasms|82005260|2005
0-14|5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60519046|2005
0-19|11.9|13.5|12.7|1068|II(a) Hodgkin lymphomas|82005260|2005
0-14|5.8|7.1|6.5|392|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|2005
0-19|8.4|9.7|9.0|748|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|2005
0-14|2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|2005
0-19|2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|2005
0-14|1.2|1.8|1.5|91|II(d) Miscellaneous lymphoreticular neoplasms|60519046|2005
0-19|1.0|1.5|1.2|102|II(d) Miscellaneous lymphoreticular neoplasms|82005260|2005
0-14|~|~|~|~|II(e) Unspecified lymphomas|60519046|2005
0-19|0.2|0.5|0.3|28|II(e) Unspecified lymphomas|82005260|2005
0-14|31.2|34.1|32.6|1971|III CNS and misc intracranial and intraspinal neoplasms|60519046|2005
0-19|28.6|31.0|29.8|2432|III CNS and misc intracranial and intraspinal neoplasms|82005260|2005
0-14|2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|2005
0-19|2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|2005
0-14|15.3|17.4|16.3|989|III(b) Astrocytomas|60519046|2005
0-19|14.3|16.0|15.2|1240|III(b) Astrocytomas|82005260|2005
0-14|6.3|7.6|6.9|418|III(c) Intracranial and intraspinal embryonal tumors|60519046|2005
0-19|5.3|6.4|5.9|475|III(c) Intracranial and intraspinal embryonal tumors|82005260|2005
0-14|4.4|5.6|5.0|300|III(d) Other gliomas|60519046|2005
0-19|4.3|5.3|4.8|389|III(d) Other gliomas|82005260|2005
0-14|0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60519046|2005
0-19|0.5|0.8|0.6|52|III(e) Other specified intracranial & intraspinal neoplasms|82005260|2005
0-14|0.3|0.7|0.5|28|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|2005
0-19|0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|2005
0-14|11.0|12.7|11.8|728|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|2005
0-19|8.4|9.8|9.1|747|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|2005
0-14|10.8|12.6|11.7|719|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|2005
0-19|8.2|9.5|8.9|729|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|2005
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|2005
0-19|0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|2005
0-14|9.8|11.5|10.6|645|IX Soft tissue and other extraosseous sarcomas|60519046|2005
0-19|11.6|13.1|12.3|1020|IX Soft tissue and other extraosseous sarcomas|82005260|2005
0-14|4.7|5.9|5.3|320|IX(a) Rhabdomyosarcomas|60519046|2005
0-19|4.4|5.4|4.9|399|IX(a) Rhabdomyosarcomas|82005260|2005
0-14|0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|2005
0-19|1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|2005
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60519046|2005
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82005260|2005
0-14|2.9|3.8|3.3|204|IX(d) Other specified soft tissue sarcomas|60519046|2005
0-19|4.4|5.4|4.9|410|IX(d) Other specified soft tissue sarcomas|82005260|2005
0-14|0.6|1.1|0.8|49|IX(e) Unspecified soft tissue sarcomas|60519046|2005
0-19|0.9|1.3|1.1|89|IX(e) Unspecified soft tissue sarcomas|82005260|2005
0-14|0.2|0.5|0.3|18|Not classified by ICCC|60519046|2005
0-19|0.2|0.4|0.3|23|Not classified by ICCC|82005260|2005
0-14|3.4|4.4|3.9|242|V Retinoblastoma|60519046|2005
0-19|2.6|3.3|3.0|244|V Retinoblastoma|82005260|2005
0-14|7.5|8.9|8.2|497|VI Renal tumors|60519046|2005
0-19|6.1|7.2|6.7|544|VI Renal tumors|82005260|2005
0-14|7.1|8.5|7.8|474|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|2005
0-19|5.5|6.6|6.0|490|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|2005
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|2005
0-19|0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|2005
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|2005
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|2005
0-14|2.0|2.8|2.4|145|VII Hepatic tumors|60519046|2005
0-19|1.7|2.3|2.0|167|VII Hepatic tumors|82005260|2005
0-14|1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|2005
0-19|1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|2005
0-14|0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|2005
0-19|0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|82005260|2005
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|2005
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|2005
0-14|6.2|7.5|6.8|415|VIII Malignant bone tumors|60519046|2005
0-19|8.2|9.5|8.8|734|VIII Malignant bone tumors|82005260|2005
0-14|3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|2005
0-19|4.5|5.5|5.0|417|VIII(a) Osteosarcomas|82005260|2005
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60519046|2005
0-19|0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|2005
0-14|2.0|2.8|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60519046|2005
0-19|2.6|3.3|2.9|241|VIII(c) Ewing tumor and related sarcomas of bone|82005260|2005
0-14|0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|2005
0-19|0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|82005260|2005
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|2005
0-19|0.1|0.3|0.2|18|VIII(e) Unspecified malignant bone tumors|82005260|2005
0-14|4.9|6.1|5.5|339|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|2005
0-19|10.7|12.2|11.4|962|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|2005
0-14|1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|2005
0-19|1.3|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|82005260|2005
0-14|1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|2005
0-19|1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|2005
0-14|1.9|2.7|2.3|139|X(c) Malignant gonadal germ cell tumors|60519046|2005
0-19|6.9|8.1|7.5|637|X(c) Malignant gonadal germ cell tumors|82005260|2005
0-14|~|~|~|~|X(d) Gonadal carcinomas|60519046|2005
0-19|0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82005260|2005
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|2005
0-19|0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|2005
0-14|6.3|7.6|6.9|423|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|2005
0-19|16.5|18.3|17.4|1464|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|2005
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|2005
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|2005
0-14|1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60519046|2005
0-19|5.5|6.6|6.1|512|XI(b) Thyroid carcinomas|82005260|2005
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|2005
0-19|0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|2005
0-14|2.1|2.9|2.4|148|XI(d) Malignant melanomas|60519046|2005
0-19|5.9|7.0|6.5|545|XI(d) Malignant melanomas|82005260|2005
0-14|~|~|~|~|XI(e) Skin carcinomas|60519046|2005
0-19|~|~|~|~|XI(e) Skin carcinomas|82005260|2005
0-14|1.6|2.3|1.9|118|XI(f) Other and unspecified carcinomas|60519046|2005
0-19|3.8|4.7|4.2|355|XI(f) Other and unspecified carcinomas|82005260|2005
0-14|0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|2005
0-19|0.7|1.1|0.9|75|XII Other and unspecified malignant neoplasms|82005260|2005
0-14|0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|2005
0-19|0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|2005
0-14|0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|2005
0-19|0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|82005260|2005
0-14|154.9|161.3|158.1|9622|All ICCC Groups Combined|60516709|2006
0-19|169.1|174.8|172.0|14272|All ICCC Groups Combined|82324418|2006
0-14|49.6|53.3|51.4|3127|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|2006
0-19|45.3|48.2|46.7|3841|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|2006
0-14|37.2|40.3|38.7|2352|I(a) Lymphoid leukemias|60516709|2006
0-19|32.0|34.5|33.2|2715|I(a) Lymphoid leukemias|82324418|2006
0-14|7.2|8.6|7.9|482|I(b) Acute myeloid leukemias|60516709|2006
0-19|7.6|8.8|8.2|681|I(b) Acute myeloid leukemias|82324418|2006
0-14|1.4|2.1|1.7|105|I(c) Chronic myeloproliferative diseases|60516709|2006
0-19|2.0|2.7|2.3|195|I(c) Chronic myeloproliferative diseases|82324418|2006
0-14|1.4|2.1|1.7|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|2006
0-19|1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|2006
0-14|1.1|1.7|1.3|82|I(e) Unspecified and other specified leukemias|60516709|2006
0-19|1.2|1.7|1.4|116|I(e) Unspecified and other specified leukemias|82324418|2006
0-14|15.7|17.8|16.7|1015|II Lymphomas and reticuloendothelial neoplasms|60516709|2006
0-19|23.9|26.0|25.0|2093|II Lymphomas and reticuloendothelial neoplasms|82324418|2006
0-14|5.5|6.8|6.1|372|II(a) Hodgkin lymphomas|60516709|2006
0-19|11.7|13.2|12.4|1051|II(a) Hodgkin lymphomas|82324418|2006
0-14|5.8|7.1|6.5|392|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|2006
0-19|8.0|9.3|8.7|723|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|2006
0-14|2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|2006
0-19|2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|2006
0-14|1.2|1.8|1.4|88|II(d) Miscellaneous lymphoreticular neoplasms|60516709|2006
0-19|0.9|1.4|1.2|96|II(d) Miscellaneous lymphoreticular neoplasms|82324418|2006
0-14|~|~|~|~|II(e) Unspecified lymphomas|60516709|2006
0-19|0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|2006
0-14|32.3|35.3|33.8|2044|III CNS and misc intracranial and intraspinal neoplasms|60516709|2006
0-19|29.7|32.2|30.9|2535|III CNS and misc intracranial and intraspinal neoplasms|82324418|2006
0-14|2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|60516709|2006
0-19|2.5|3.2|2.8|231|III(a) Ependymomas and choroid plexus tumor|82324418|2006
0-14|15.2|17.3|16.2|983|III(b) Astrocytomas|60516709|2006
0-19|14.4|16.1|15.2|1252|III(b) Astrocytomas|82324418|2006
0-14|7.0|8.4|7.7|464|III(c) Intracranial and intraspinal embryonal tumors|60516709|2006
0-19|5.8|6.9|6.3|515|III(c) Intracranial and intraspinal embryonal tumors|82324418|2006
0-14|5.1|6.3|5.7|340|III(d) Other gliomas|60516709|2006
0-19|4.9|5.9|5.4|440|III(d) Other gliomas|82324418|2006
0-14|0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|2006
0-19|0.4|0.8|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|82324418|2006
0-14|0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|2006
0-19|0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|2006
0-14|9.5|11.1|10.3|633|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|2006
0-19|7.3|8.5|7.9|649|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|2006
0-14|9.4|11.0|10.2|628|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|2006
0-19|7.1|8.3|7.7|636|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|2006
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|2006
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|2006
0-14|9.7|11.3|10.5|638|IX Soft tissue and other extraosseous sarcomas|60516709|2006
0-19|10.9|12.3|11.6|962|IX Soft tissue and other extraosseous sarcomas|82324418|2006
0-14|4.3|5.5|4.9|295|IX(a) Rhabdomyosarcomas|60516709|2006
0-19|4.1|5.0|4.6|374|IX(a) Rhabdomyosarcomas|82324418|2006
0-14|0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|2006
0-19|1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|2006
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60516709|2006
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82324418|2006
0-14|3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|60516709|2006
0-19|4.0|4.9|4.5|373|IX(d) Other specified soft tissue sarcomas|82324418|2006
0-14|0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60516709|2006
0-19|1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82324418|2006
0-14|~|~|~|~|Not classified by ICCC|60516709|2006
0-19|0.2|0.4|0.3|24|Not classified by ICCC|82324418|2006
0-14|3.6|4.6|4.1|252|V Retinoblastoma|60516709|2006
0-19|2.7|3.4|3.0|253|V Retinoblastoma|82324418|2006
0-14|7.5|9.0|8.2|502|VI Renal tumors|60516709|2006
0-19|6.1|7.3|6.7|547|VI Renal tumors|82324418|2006
0-14|7.2|8.6|7.9|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|2006
0-19|5.4|6.5|6.0|486|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|2006
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|60516709|2006
0-19|0.5|0.9|0.7|56|VI(b) Renal carcinomas|82324418|2006
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|2006
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|2006
0-14|2.2|3.0|2.6|161|VII Hepatic tumors|60516709|2006
0-19|2.0|2.7|2.3|192|VII Hepatic tumors|82324418|2006
0-14|1.8|2.6|2.2|134|VII(a) Hepatoblastoma|60516709|2006
0-19|1.4|1.9|1.6|136|VII(a) Hepatoblastoma|82324418|2006
0-14|0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|2006
0-19|0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82324418|2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|2006
0-14|6.4|7.8|7.1|429|VIII Malignant bone tumors|60516709|2006
0-19|8.7|10.0|9.3|779|VIII Malignant bone tumors|82324418|2006
0-14|3.5|4.6|4.0|245|VIII(a) Osteosarcomas|60516709|2006
0-19|4.9|5.9|5.4|452|VIII(a) Osteosarcomas|82324418|2006
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60516709|2006
0-19|0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|2006
0-14|2.1|2.9|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60516709|2006
0-19|2.7|3.4|3.0|252|VIII(c) Ewing tumor and related sarcomas of bone|82324418|2006
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|2006
0-19|0.4|0.7|0.5|43|VIII(d) Other specified malignant bone tumors|82324418|2006
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|2006
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|2006
0-14|4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|2006
0-19|9.5|10.9|10.2|866|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|2006
0-14|1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|2006
0-19|1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|2006
0-14|1.2|1.8|1.5|92|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|2006
0-19|1.2|1.8|1.5|126|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|2006
0-14|1.7|2.5|2.1|128|X(c) Malignant gonadal germ cell tumors|60516709|2006
0-19|5.8|6.9|6.4|544|X(c) Malignant gonadal germ cell tumors|82324418|2006
0-14|~|~|~|~|X(d) Gonadal carcinomas|60516709|2006
0-19|0.3|0.6|0.5|41|X(d) Gonadal carcinomas|82324418|2006
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|2006
0-19|0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|2006
0-14|6.8|8.1|7.4|453|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|2006
0-19|16.3|18.0|17.1|1457|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|2006
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|2006
0-19|0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|2006
0-14|2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60516709|2006
0-19|6.1|7.2|6.6|566|XI(b) Thyroid carcinomas|82324418|2006
0-14|0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|2006
0-19|0.5|0.8|0.6|55|XI(c) Nasopharyngeal carcinomas|82324418|2006
0-14|2.1|2.9|2.4|148|XI(d) Malignant melanomas|60516709|2006
0-19|4.9|5.9|5.4|459|XI(d) Malignant melanomas|82324418|2006
0-14|~|~|~|~|XI(e) Skin carcinomas|60516709|2006
0-19|~|~|~|~|XI(e) Skin carcinomas|82324418|2006
0-14|1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|60516709|2006
0-19|3.7|4.6|4.2|354|XI(f) Other and unspecified carcinomas|82324418|2006
0-14|0.5|1.0|0.8|46|XII Other and unspecified malignant neoplasms|60516709|2006
0-19|0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82324418|2006
0-14|0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|2006
0-19|0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|2006
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60516709|2006
0-19|0.3|0.6|0.4|33|XII(b) Other unspecified malignant tumors|82324418|2006
0-14|158.2|164.6|161.4|9863|All ICCC Groups Combined|60681615|2007
0-19|173.1|178.9|176.0|14705|All ICCC Groups Combined|82749431|2007
0-14|50.2|53.8|52.0|3171|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|2007
0-19|45.7|48.7|47.2|3900|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|2007
0-14|38.4|41.6|39.9|2433|I(a) Lymphoid leukemias|60681615|2007
0-19|33.0|35.5|34.2|2812|I(a) Lymphoid leukemias|82749431|2007
0-14|7.0|8.4|7.7|470|I(b) Acute myeloid leukemias|60681615|2007
0-19|7.3|8.6|7.9|663|I(b) Acute myeloid leukemias|82749431|2007
0-14|1.3|2.0|1.6|99|I(c) Chronic myeloproliferative diseases|60681615|2007
0-19|2.1|2.8|2.4|207|I(c) Chronic myeloproliferative diseases|82749431|2007
0-14|1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|2007
0-19|1.2|1.7|1.5|122|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|2007
0-14|0.9|1.5|1.2|74|I(e) Unspecified and other specified leukemias|60681615|2007
0-19|0.9|1.4|1.2|96|I(e) Unspecified and other specified leukemias|82749431|2007
0-14|15.6|17.7|16.6|1007|II Lymphomas and reticuloendothelial neoplasms|60681615|2007
0-19|23.8|26.0|24.9|2100|II Lymphomas and reticuloendothelial neoplasms|82749431|2007
0-14|4.9|6.0|5.4|329|II(a) Hodgkin lymphomas|60681615|2007
0-19|11.4|12.8|12.1|1033|II(a) Hodgkin lymphomas|82749431|2007
0-14|6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|2007
0-19|8.1|9.4|8.7|727|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|2007
0-14|2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|2007
0-19|2.3|3.0|2.6|215|II(c) Burkitt lymphoma|82749431|2007
0-14|1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60681615|2007
0-19|0.9|1.3|1.1|90|II(d) Miscellaneous lymphoreticular neoplasms|82749431|2007
0-14|~|~|~|~|II(e) Unspecified lymphomas|60681615|2007
0-19|0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|2007
0-14|33.5|36.4|34.9|2122|III CNS and misc intracranial and intraspinal neoplasms|60681615|2007
0-19|30.4|32.8|31.6|2598|III CNS and misc intracranial and intraspinal neoplasms|82749431|2007
0-14|2.5|3.4|2.9|177|III(a) Ependymomas and choroid plexus tumor|60681615|2007
0-19|2.2|2.9|2.5|207|III(a) Ependymomas and choroid plexus tumor|82749431|2007
0-14|15.5|17.6|16.6|1005|III(b) Astrocytomas|60681615|2007
0-19|14.9|16.6|15.7|1299|III(b) Astrocytomas|82749431|2007
0-14|7.0|8.5|7.7|470|III(c) Intracranial and intraspinal embryonal tumors|60681615|2007
0-19|5.9|7.1|6.5|531|III(c) Intracranial and intraspinal embryonal tumors|82749431|2007
0-14|5.9|7.2|6.5|393|III(d) Other gliomas|60681615|2007
0-19|5.2|6.2|5.7|465|III(d) Other gliomas|82749431|2007
0-14|0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|60681615|2007
0-19|0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|82749431|2007
0-14|0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|2007
0-19|0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|2007
0-14|10.9|12.6|11.7|732|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|2007
0-19|8.3|9.6|9.0|750|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|2007
0-14|10.7|12.4|11.5|720|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|2007
0-19|8.1|9.4|8.8|731|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|2007
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|2007
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|2007
0-14|10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|60681615|2007
0-19|11.8|13.3|12.5|1046|IX Soft tissue and other extraosseous sarcomas|82749431|2007
0-14|5.1|6.3|5.7|348|IX(a) Rhabdomyosarcomas|60681615|2007
0-19|4.7|5.7|5.2|427|IX(a) Rhabdomyosarcomas|82749431|2007
0-14|0.9|1.4|1.1|70|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|2007
0-19|1.1|1.6|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|2007
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60681615|2007
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82749431|2007
0-14|2.9|3.8|3.3|201|IX(d) Other specified soft tissue sarcomas|60681615|2007
0-19|4.3|5.2|4.7|401|IX(d) Other specified soft tissue sarcomas|82749431|2007
0-14|0.6|1.1|0.9|52|IX(e) Unspecified soft tissue sarcomas|60681615|2007
0-19|1.0|1.4|1.2|99|IX(e) Unspecified soft tissue sarcomas|82749431|2007
0-14|~|~|~|~|Not classified by ICCC|60681615|2007
0-19|0.1|0.3|0.2|18|Not classified by ICCC|82749431|2007
0-14|3.7|4.8|4.2|267|V Retinoblastoma|60681615|2007
0-19|2.8|3.6|3.2|267|V Retinoblastoma|82749431|2007
0-14|7.9|9.3|8.6|527|VI Renal tumors|60681615|2007
0-19|6.3|7.5|6.9|567|VI Renal tumors|82749431|2007
0-14|7.4|8.9|8.1|500|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|2007
0-19|5.7|6.8|6.2|511|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|2007
0-14|0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|2007
0-19|0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|2007
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|2007
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|2007
0-14|2.2|3.0|2.6|160|VII Hepatic tumors|60681615|2007
0-19|2.0|2.7|2.3|195|VII Hepatic tumors|82749431|2007
0-14|1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|2007
0-19|1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|2007
0-14|0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|60681615|2007
0-19|0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82749431|2007
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|2007
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|2007
0-14|6.2|7.5|6.8|412|VIII Malignant bone tumors|60681615|2007
0-19|8.1|9.4|8.8|733|VIII Malignant bone tumors|82749431|2007
0-14|3.2|4.2|3.7|221|VIII(a) Osteosarcomas|60681615|2007
0-19|4.2|5.2|4.7|393|VIII(a) Osteosarcomas|82749431|2007
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60681615|2007
0-19|0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|82749431|2007
0-14|2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|2007
0-19|2.7|3.5|3.1|257|VIII(c) Ewing tumor and related sarcomas of bone|82749431|2007
0-14|0.2|0.4|0.3|16|VIII(d) Other specified malignant bone tumors|60681615|2007
0-19|0.2|0.5|0.3|29|VIII(d) Other specified malignant bone tumors|82749431|2007
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|2007
0-19|0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82749431|2007
0-14|4.9|6.1|5.5|337|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|2007
0-19|10.4|11.8|11.1|952|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|2007
0-14|1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|60681615|2007
0-19|1.3|1.9|1.6|134|X(a) Intracranial & intraspinal germ cell tumors|82749431|2007
0-14|1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|2007
0-19|1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|2007
0-14|2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|2007
0-19|6.9|8.1|7.5|644|X(c) Malignant gonadal germ cell tumors|82749431|2007
0-14|~|~|~|~|X(d) Gonadal carcinomas|60681615|2007
0-19|0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82749431|2007
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|2007
0-19|0.2|0.4|0.3|25|X(e) Other and unspecified malignant gonadal tumors|82749431|2007
0-14|6.0|7.3|6.6|404|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|2007
0-19|16.7|18.5|17.6|1512|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|2007
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|2007
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|2007
0-14|1.9|2.7|2.2|137|XI(b) Thyroid carcinomas|60681615|2007
0-19|6.7|7.9|7.3|627|XI(b) Thyroid carcinomas|82749431|2007
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|2007
0-19|0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|2007
0-14|1.8|2.6|2.2|132|XI(d) Malignant melanomas|60681615|2007
0-19|4.9|5.9|5.4|461|XI(d) Malignant melanomas|82749431|2007
0-14|~|~|~|~|XI(e) Skin carcinomas|60681615|2007
0-19|~|~|~|~|XI(e) Skin carcinomas|82749431|2007
0-14|1.4|2.0|1.7|101|XI(f) Other and unspecified carcinomas|60681615|2007
0-19|3.6|4.5|4.1|348|XI(f) Other and unspecified carcinomas|82749431|2007
0-14|0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|2007
0-19|0.6|1.0|0.8|67|XII Other and unspecified malignant neoplasms|82749431|2007
0-14|0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|2007
0-19|0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|2007
0-14|0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|2007
0-19|0.3|0.6|0.4|38|XII(b) Other unspecified malignant tumors|82749431|2007
0-14|160.4|166.9|163.6|10040|All ICCC Groups Combined|60907384|2008
0-19|174.8|180.5|177.6|14908|All ICCC Groups Combined|83118264|2008
0-14|52.0|55.7|53.8|3302|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|2008
0-19|47.1|50.1|48.5|4034|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|2008
0-14|39.3|42.5|40.9|2508|I(a) Lymphoid leukemias|60907384|2008
0-19|33.7|36.2|34.9|2890|I(a) Lymphoid leukemias|83118264|2008
0-14|7.3|8.7|8.0|493|I(b) Acute myeloid leukemias|60907384|2008
0-19|7.7|8.9|8.3|698|I(b) Acute myeloid leukemias|83118264|2008
0-14|1.7|2.5|2.1|128|I(c) Chronic myeloproliferative diseases|60907384|2008
0-19|2.3|3.0|2.6|222|I(c) Chronic myeloproliferative diseases|83118264|2008
0-14|1.4|2.0|1.7|103|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|2008
0-19|1.3|1.9|1.6|131|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|2008
0-14|0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|60907384|2008
0-19|0.9|1.4|1.1|93|I(e) Unspecified and other specified leukemias|83118264|2008
0-14|16.1|18.2|17.1|1038|II Lymphomas and reticuloendothelial neoplasms|60907384|2008
0-19|24.3|26.5|25.4|2151|II Lymphomas and reticuloendothelial neoplasms|83118264|2008
0-14|5.7|7.0|6.3|381|II(a) Hodgkin lymphomas|60907384|2008
0-19|12.2|13.7|12.9|1104|II(a) Hodgkin lymphomas|83118264|2008
0-14|6.1|7.4|6.7|407|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|2008
0-19|8.1|9.4|8.7|734|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|2008
0-14|2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|2008
0-19|2.2|2.9|2.5|210|II(c) Burkitt lymphoma|83118264|2008
0-14|0.9|1.5|1.2|73|II(d) Miscellaneous lymphoreticular neoplasms|60907384|2008
0-19|0.7|1.2|0.9|77|II(d) Miscellaneous lymphoreticular neoplasms|83118264|2008
0-14|~|~|~|~|II(e) Unspecified lymphomas|60907384|2008
0-19|0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|2008
0-14|33.4|36.4|34.9|2132|III CNS and misc intracranial and intraspinal neoplasms|60907384|2008
0-19|30.6|33.1|31.8|2635|III CNS and misc intracranial and intraspinal neoplasms|83118264|2008
0-14|2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60907384|2008
0-19|2.0|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|83118264|2008
0-14|16.2|18.3|17.2|1047|III(b) Astrocytomas|60907384|2008
0-19|15.1|16.9|16.0|1322|III(b) Astrocytomas|83118264|2008
0-14|7.4|8.8|8.1|497|III(c) Intracranial and intraspinal embryonal tumors|60907384|2008
0-19|6.2|7.3|6.7|554|III(c) Intracranial and intraspinal embryonal tumors|83118264|2008
0-14|5.3|6.6|5.9|359|III(d) Other gliomas|60907384|2008
0-19|5.2|6.2|5.7|469|III(d) Other gliomas|83118264|2008
0-14|0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|2008
0-19|0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83118264|2008
0-14|0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|2008
0-19|0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|2008
0-14|10.1|11.7|10.9|682|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|2008
0-19|7.7|9.0|8.3|699|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|2008
0-14|9.8|11.4|10.6|665|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|2008
0-19|7.4|8.7|8.0|673|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|2008
0-14|0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|2008
0-19|0.2|0.5|0.3|26|IV(b) Other peripheral nervous cell tumors|83118264|2008
0-14|10.1|11.8|10.9|667|IX Soft tissue and other extraosseous sarcomas|60907384|2008
0-19|11.5|13.0|12.2|1023|IX Soft tissue and other extraosseous sarcomas|83118264|2008
0-14|4.7|5.9|5.3|324|IX(a) Rhabdomyosarcomas|60907384|2008
0-19|4.6|5.6|5.1|424|IX(a) Rhabdomyosarcomas|83118264|2008
0-14|0.7|1.2|0.9|57|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|2008
0-19|0.9|1.3|1.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|2008
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60907384|2008
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83118264|2008
0-14|3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|60907384|2008
0-19|4.1|5.0|4.5|382|IX(d) Other specified soft tissue sarcomas|83118264|2008
0-14|1.0|1.6|1.3|77|IX(e) Unspecified soft tissue sarcomas|60907384|2008
0-19|1.2|1.8|1.5|125|IX(e) Unspecified soft tissue sarcomas|83118264|2008
0-14|0.1|0.4|0.3|16|Not classified by ICCC|60907384|2008
0-19|0.2|0.4|0.3|23|Not classified by ICCC|83118264|2008
0-14|3.7|4.7|4.2|263|V Retinoblastoma|60907384|2008
0-19|2.7|3.5|3.1|263|V Retinoblastoma|83118264|2008
0-14|8.2|9.8|9.0|556|VI Renal tumors|60907384|2008
0-19|6.6|7.8|7.2|600|VI Renal tumors|83118264|2008
0-14|7.8|9.3|8.5|529|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|2008
0-19|5.9|7.0|6.4|534|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|2008
0-14|0.3|0.6|0.4|25|VI(b) Renal carcinomas|60907384|2008
0-19|0.6|0.9|0.7|63|VI(b) Renal carcinomas|83118264|2008
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|2008
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|2008
0-14|2.2|3.1|2.6|164|VII Hepatic tumors|60907384|2008
0-19|1.9|2.6|2.3|190|VII Hepatic tumors|83118264|2008
0-14|1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|2008
0-19|1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|2008
0-14|0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|2008
0-19|0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|2008
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|2008
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|2008
0-14|6.2|7.5|6.8|413|VIII Malignant bone tumors|60907384|2008
0-19|8.1|9.4|8.7|733|VIII Malignant bone tumors|83118264|2008
0-14|3.4|4.4|3.8|232|VIII(a) Osteosarcomas|60907384|2008
0-19|4.5|5.4|4.9|414|VIII(a) Osteosarcomas|83118264|2008
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60907384|2008
0-19|0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|2008
0-14|2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|2008
0-19|2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|2008
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|2008
0-19|0.3|0.5|0.4|32|VIII(d) Other specified malignant bone tumors|83118264|2008
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|2008
0-19|0.2|0.4|0.2|21|VIII(e) Unspecified malignant bone tumors|83118264|2008
0-14|4.7|5.8|5.2|323|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|2008
0-19|10.2|11.6|10.9|938|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|2008
0-14|1.1|1.7|1.4|82|X(a) Intracranial & intraspinal germ cell tumors|60907384|2008
0-19|1.5|2.0|1.7|145|X(a) Intracranial & intraspinal germ cell tumors|83118264|2008
0-14|1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|2008
0-19|1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|2008
0-14|1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|2008
0-19|6.7|7.8|7.2|629|X(c) Malignant gonadal germ cell tumors|83118264|2008
0-14|~|~|~|~|X(d) Gonadal carcinomas|60907384|2008
0-19|0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|2008
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|2008
0-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|2008
0-14|6.6|8.0|7.3|445|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|2008
0-19|17.2|19.0|18.1|1557|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|2008
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60907384|2008
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|83118264|2008
0-14|2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60907384|2008
0-19|7.4|8.6|8.0|694|XI(b) Thyroid carcinomas|83118264|2008
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|2008
0-19|0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|2008
0-14|1.9|2.7|2.3|139|XI(d) Malignant melanomas|60907384|2008
0-19|4.4|5.3|4.9|417|XI(d) Malignant melanomas|83118264|2008
0-14|~|~|~|~|XI(e) Skin carcinomas|60907384|2008
0-19|~|~|~|~|XI(e) Skin carcinomas|83118264|2008
0-14|1.5|2.3|1.9|114|XI(f) Other and unspecified carcinomas|60907384|2008
0-19|3.9|4.8|4.4|377|XI(f) Other and unspecified carcinomas|83118264|2008
0-14|0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|2008
0-19|0.6|0.9|0.7|62|XII Other and unspecified malignant neoplasms|83118264|2008
0-14|0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|2008
0-19|0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|83118264|2008
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|2008
0-19|0.2|0.5|0.4|31|XII(b) Other unspecified malignant tumors|83118264|2008
0-14|163.8|166.7|165.2|50263|All ICCC Groups Combined|302737371|2008-2012
0-19|177.6|180.2|178.9|74104|All ICCC Groups Combined|411224220|2008-2012
0-14|52.0|53.7|52.8|16110|I Leukemias, myeloproliferative & myelodysplastic diseases|302737371|2008-2012
0-19|47.1|48.4|47.8|19647|I Leukemias, myeloproliferative & myelodysplastic diseases|411224220|2008-2012
0-14|39.8|41.2|40.5|12351|I(a) Lymphoid leukemias|302737371|2008-2012
0-19|33.8|35.0|34.4|14109|I(a) Lymphoid leukemias|411224220|2008-2012
0-14|7.2|7.8|7.5|2274|I(b) Acute myeloid leukemias|302737371|2008-2012
0-19|7.7|8.2|8.0|3299|I(b) Acute myeloid leukemias|411224220|2008-2012
0-14|1.6|1.9|1.8|542|I(c) Chronic myeloproliferative diseases|302737371|2008-2012
0-19|2.3|2.6|2.4|1006|I(c) Chronic myeloproliferative diseases|411224220|2008-2012
0-14|1.5|1.8|1.6|493|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|302737371|2008-2012
0-19|1.4|1.7|1.5|634|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|411224220|2008-2012
0-14|1.3|1.6|1.5|450|I(e) Unspecified and other specified leukemias|302737371|2008-2012
0-19|1.3|1.6|1.5|599|I(e) Unspecified and other specified leukemias|411224220|2008-2012
0-14|18.4|19.4|18.9|5716|II Lymphomas and reticuloendothelial neoplasms|302737371|2008-2012
0-19|26.5|27.5|27.0|11236|II Lymphomas and reticuloendothelial neoplasms|411224220|2008-2012
0-14|5.4|5.9|5.6|1691|II(a) Hodgkin lymphomas|302737371|2008-2012
0-19|12.0|12.7|12.4|5207|II(a) Hodgkin lymphomas|411224220|2008-2012
0-14|6.7|7.3|7.0|2102|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|302737371|2008-2012
0-19|8.6|9.2|8.9|3687|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|411224220|2008-2012
0-14|2.3|2.7|2.5|744|II(c) Burkitt lymphoma|302737371|2008-2012
0-19|2.2|2.5|2.4|974|II(c) Burkitt lymphoma|411224220|2008-2012
0-14|3.4|3.9|3.6|1109|II(d) Miscellaneous lymphoreticular neoplasms|302737371|2008-2012
0-19|2.8|3.2|3.0|1223|II(d) Miscellaneous lymphoreticular neoplasms|411224220|2008-2012
0-14|0.2|0.3|0.2|70|II(e) Unspecified lymphomas|302737371|2008-2012
0-19|0.3|0.4|0.3|145|II(e) Unspecified lymphomas|411224220|2008-2012
0-14|34.1|35.4|34.8|10548|III CNS and misc intracranial and intraspinal neoplasms|302737371|2008-2012
0-19|31.0|32.1|31.6|12948|III CNS and misc intracranial and intraspinal neoplasms|411224220|2008-2012
0-14|2.7|3.1|2.9|897|III(a) Ependymomas and choroid plexus tumor|302737371|2008-2012
0-19|2.5|2.8|2.6|1073|III(a) Ependymomas and choroid plexus tumor|411224220|2008-2012
0-14|17.0|17.9|17.4|5285|III(b) Astrocytomas|302737371|2008-2012
0-19|15.8|16.6|16.2|6649|III(b) Astrocytomas|411224220|2008-2012
0-14|7.1|7.7|7.4|2257|III(c) Intracranial and intraspinal embryonal tumors|302737371|2008-2012
0-19|6.0|6.4|6.2|2533|III(c) Intracranial and intraspinal embryonal tumors|411224220|2008-2012
0-14|5.6|6.2|5.9|1781|III(d) Other gliomas|302737371|2008-2012
0-19|5.3|5.8|5.5|2263|III(d) Other gliomas|411224220|2008-2012
0-14|0.5|0.7|0.6|181|III(e) Other specified intracranial & intraspinal neoplasms|302737371|2008-2012
0-19|0.5|0.7|0.6|244|III(e) Other specified intracranial & intraspinal neoplasms|411224220|2008-2012
0-14|0.4|0.6|0.5|147|III(f) Unspecified intracranial and intraspinal neoplasms|302737371|2008-2012
0-19|0.4|0.5|0.5|186|III(f) Unspecified intracranial and intraspinal neoplasms|411224220|2008-2012
0-14|10.6|11.4|11.0|3390|IV Neuroblastoma and other peripheral nervous cell tumors|302737371|2008-2012
0-19|8.2|8.7|8.4|3471|IV Neuroblastoma and other peripheral nervous cell tumors|411224220|2008-2012
0-14|10.4|11.2|10.8|3329|IV(a) Neuroblastoma and ganglioneuroblastoma|302737371|2008-2012
0-19|7.9|8.5|8.2|3372|IV(a) Neuroblastoma and ganglioneuroblastoma|411224220|2008-2012
0-14|0.2|0.3|0.2|61|IV(b) Other peripheral nervous cell tumors|302737371|2008-2012
0-19|0.2|0.3|0.2|99|IV(b) Other peripheral nervous cell tumors|411224220|2008-2012
0-14|10.6|11.4|11.0|3331|IX Soft tissue and other extraosseous sarcomas|302737371|2008-2012
0-19|11.8|12.4|12.1|4999|IX Soft tissue and other extraosseous sarcomas|411224220|2008-2012
0-14|4.8|5.4|5.1|1551|IX(a) Rhabdomyosarcomas|302737371|2008-2012
0-19|4.5|5.0|4.8|1954|IX(a) Rhabdomyosarcomas|411224220|2008-2012
0-14|0.9|1.1|1.0|308|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|302737371|2008-2012
0-19|1.1|1.3|1.2|502|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|411224220|2008-2012
0-14|~|~|~|~|IX(c) Kaposi sarcoma|302737371|2008-2012
0-19|0.0|0.1|0.1|26|IX(c) Kaposi sarcoma|411224220|2008-2012
0-14|3.4|3.9|3.7|1104|IX(d) Other specified soft tissue sarcomas|302737371|2008-2012
0-19|4.4|4.9|4.6|1927|IX(d) Other specified soft tissue sarcomas|411224220|2008-2012
0-14|1.1|1.3|1.2|361|IX(e) Unspecified soft tissue sarcomas|302737371|2008-2012
0-19|1.3|1.5|1.4|590|IX(e) Unspecified soft tissue sarcomas|411224220|2008-2012
0-14|0.2|0.3|0.3|82|Not classified by ICCC|302737371|2008-2012
0-19|0.2|0.3|0.3|120|Not classified by ICCC|411224220|2008-2012
0-14|4.1|4.5|4.3|1329|V Retinoblastoma|302737371|2008-2012
0-19|3.1|3.4|3.2|1330|V Retinoblastoma|411224220|2008-2012
0-14|8.5|9.2|8.8|2706|VI Renal tumors|302737371|2008-2012
0-19|6.8|7.3|7.1|2906|VI Renal tumors|411224220|2008-2012
0-14|8.1|8.7|8.4|2573|VI(a) Nephroblastoma and other nonepithelial renal tumors|302737371|2008-2012
0-19|6.1|6.6|6.4|2610|VI(a) Nephroblastoma and other nonepithelial renal tumors|411224220|2008-2012
0-14|0.3|0.5|0.4|120|VI(b) Renal carcinomas|302737371|2008-2012
0-19|0.6|0.8|0.7|282|VI(b) Renal carcinomas|411224220|2008-2012
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|302737371|2008-2012
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|411224220|2008-2012
0-14|2.7|3.1|2.9|879|VII Hepatic tumors|302737371|2008-2012
0-19|2.3|2.6|2.4|1011|VII Hepatic tumors|411224220|2008-2012
0-14|2.2|2.6|2.4|747|VII(a) Hepatoblastoma|302737371|2008-2012
0-19|1.7|2.0|1.8|754|VII(a) Hepatoblastoma|411224220|2008-2012
0-14|0.3|0.5|0.4|124|VII(b) Hepatic carcinomas|302737371|2008-2012
0-19|0.5|0.7|0.6|247|VII(b) Hepatic carcinomas|411224220|2008-2012
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|302737371|2008-2012
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|411224220|2008-2012
0-14|6.7|7.3|7.0|2104|VIII Malignant bone tumors|302737371|2008-2012
0-19|8.4|9.0|8.7|3609|VIII Malignant bone tumors|411224220|2008-2012
0-14|3.8|4.2|4.0|1200|VIII(a) Osteosarcomas|302737371|2008-2012
0-19|4.8|5.2|5.0|2060|VIII(a) Osteosarcomas|411224220|2008-2012
0-14|0.1|0.2|0.1|42|VIII(b) Chondrosarcomas|302737371|2008-2012
0-19|0.3|0.4|0.3|135|VIII(b) Chondrosarcomas|411224220|2008-2012
0-14|2.3|2.6|2.4|730|VIII(c) Ewing tumor and related sarcomas of bone|302737371|2008-2012
0-19|2.7|3.0|2.8|1170|VIII(c) Ewing tumor and related sarcomas of bone|411224220|2008-2012
0-14|0.2|0.3|0.3|85|VIII(d) Other specified malignant bone tumors|302737371|2008-2012
0-19|0.3|0.5|0.4|161|VIII(d) Other specified malignant bone tumors|411224220|2008-2012
0-14|0.1|0.2|0.2|47|VIII(e) Unspecified malignant bone tumors|302737371|2008-2012
0-19|0.2|0.2|0.2|83|VIII(e) Unspecified malignant bone tumors|411224220|2008-2012
0-14|5.1|5.7|5.4|1634|X Germ cell, trophoblastic tumors & neoplasms of gonads|302737371|2008-2012
0-19|10.9|11.5|11.2|4712|X Germ cell, trophoblastic tumors & neoplasms of gonads|411224220|2008-2012
0-14|1.4|1.6|1.5|449|X(a) Intracranial & intraspinal germ cell tumors|302737371|2008-2012
0-19|1.6|1.9|1.7|711|X(a) Intracranial & intraspinal germ cell tumors|411224220|2008-2012
0-14|1.2|1.4|1.3|399|X(b) Malignant extracranial & extragonadal germ cell tumors|302737371|2008-2012
0-19|1.3|1.5|1.4|587|X(b) Malignant extracranial & extragonadal germ cell tumors|411224220|2008-2012
0-14|2.2|2.5|2.3|710|X(c) Malignant gonadal germ cell tumors|302737371|2008-2012
0-19|7.1|7.6|7.3|3107|X(c) Malignant gonadal germ cell tumors|411224220|2008-2012
0-14|0.1|0.2|0.1|35|X(d) Gonadal carcinomas|302737371|2008-2012
0-19|0.4|0.5|0.4|188|X(d) Gonadal carcinomas|411224220|2008-2012
0-14|0.1|0.2|0.1|41|X(e) Other and unspecified malignant gonadal tumors|302737371|2008-2012
0-19|0.2|0.3|0.3|119|X(e) Other and unspecified malignant gonadal tumors|411224220|2008-2012
0-14|7.1|7.7|7.4|2225|XI Other malignant epithelial neoplasms and malignant melanomas|302737371|2008-2012
0-19|18.0|18.8|18.4|7791|XI Other malignant epithelial neoplasms and malignant melanomas|411224220|2008-2012
0-14|0.2|0.3|0.2|72|XI(a) Adrenocortical carcinomas|302737371|2008-2012
0-19|0.2|0.3|0.2|101|XI(a) Adrenocortical carcinomas|411224220|2008-2012
0-14|2.8|3.2|3.0|890|XI(b) Thyroid carcinomas|302737371|2008-2012
0-19|8.4|8.9|8.6|3664|XI(b) Thyroid carcinomas|411224220|2008-2012
0-14|0.2|0.4|0.3|91|XI(c) Nasopharyngeal carcinomas|302737371|2008-2012
0-19|0.5|0.7|0.6|243|XI(c) Nasopharyngeal carcinomas|411224220|2008-2012
0-14|1.8|2.1|2.0|598|XI(d) Malignant melanomas|302737371|2008-2012
0-19|4.2|4.6|4.4|1848|XI(d) Malignant melanomas|411224220|2008-2012
0-14|~|~|~|~|XI(e) Skin carcinomas|302737371|2008-2012
0-19|0.1|0.1|0.1|35|XI(e) Skin carcinomas|411224220|2008-2012
0-14|1.7|2.0|1.9|560|XI(f) Other and unspecified carcinomas|302737371|2008-2012
0-19|4.3|4.7|4.5|1900|XI(f) Other and unspecified carcinomas|411224220|2008-2012
0-14|0.6|0.8|0.7|209|XII Other and unspecified malignant neoplasms|302737371|2008-2012
0-19|0.7|0.9|0.8|324|XII Other and unspecified malignant neoplasms|411224220|2008-2012
0-14|0.3|0.4|0.3|104|XII(a) Other specified malignant tumors|302737371|2008-2012
0-19|0.3|0.4|0.4|149|XII(a) Other specified malignant tumors|411224220|2008-2012
0-14|0.3|0.4|0.3|105|XII(b) Other unspecified malignant tumors|302737371|2008-2012
0-19|0.4|0.5|0.4|175|XII(b) Other unspecified malignant tumors|411224220|2008-2012
0-14|158.8|165.2|162.0|9954|All ICCC Groups Combined|61087581|2009
0-19|173.7|179.4|176.5|14830|All ICCC Groups Combined|83280391|2009
0-14|50.4|54.0|52.2|3216|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|2009
0-19|45.5|48.5|47.0|3917|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|2009
0-14|39.2|42.4|40.8|2513|I(a) Lymphoid leukemias|61087581|2009
0-19|33.2|35.8|34.5|2864|I(a) Lymphoid leukemias|83280391|2009
0-14|6.6|8.0|7.3|447|I(b) Acute myeloid leukemias|61087581|2009
0-19|7.0|8.2|7.6|640|I(b) Acute myeloid leukemias|83280391|2009
0-14|1.2|1.9|1.5|94|I(c) Chronic myeloproliferative diseases|61087581|2009
0-19|2.0|2.6|2.3|193|I(c) Chronic myeloproliferative diseases|83280391|2009
0-14|1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|2009
0-19|1.2|1.7|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|2009
0-14|0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|2009
0-19|0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|2009
0-14|15.8|17.9|16.8|1023|II Lymphomas and reticuloendothelial neoplasms|61087581|2009
0-19|24.1|26.3|25.2|2137|II Lymphomas and reticuloendothelial neoplasms|83280391|2009
0-14|5.1|6.3|5.7|346|II(a) Hodgkin lymphomas|61087581|2009
0-19|11.8|13.3|12.6|1078|II(a) Hodgkin lymphomas|83280391|2009
0-14|6.3|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|2009
0-19|8.2|9.5|8.8|743|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|2009
0-14|2.0|2.8|2.3|142|II(c) Burkitt lymphoma|61087581|2009
0-19|1.9|2.6|2.2|183|II(c) Burkitt lymphoma|83280391|2009
0-14|1.3|1.9|1.6|99|II(d) Miscellaneous lymphoreticular neoplasms|61087581|2009
0-19|1.1|1.6|1.3|107|II(d) Miscellaneous lymphoreticular neoplasms|83280391|2009
0-14|~|~|~|~|II(e) Unspecified lymphomas|61087581|2009
0-19|0.2|0.4|0.3|26|II(e) Unspecified lymphomas|83280391|2009
0-14|33.5|36.4|34.9|2139|III CNS and misc intracranial and intraspinal neoplasms|61087581|2009
0-19|30.3|32.8|31.5|2615|III CNS and misc intracranial and intraspinal neoplasms|83280391|2009
0-14|2.2|3.0|2.6|159|III(a) Ependymomas and choroid plexus tumor|61087581|2009
0-19|2.1|2.8|2.5|206|III(a) Ependymomas and choroid plexus tumor|83280391|2009
0-14|16.1|18.2|17.2|1051|III(b) Astrocytomas|61087581|2009
0-19|15.0|16.7|15.8|1315|III(b) Astrocytomas|83280391|2009
0-14|6.9|8.3|7.6|464|III(c) Intracranial and intraspinal embryonal tumors|61087581|2009
0-19|5.8|6.9|6.3|521|III(c) Intracranial and intraspinal embryonal tumors|83280391|2009
0-14|5.9|7.2|6.5|399|III(d) Other gliomas|61087581|2009
0-19|5.4|6.4|5.9|486|III(d) Other gliomas|83280391|2009
0-14|0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|2009
0-19|0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|83280391|2009
0-14|0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|2009
0-19|0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|2009
0-14|10.0|11.6|10.8|670|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|2009
0-19|7.6|8.9|8.2|684|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|2009
0-14|9.8|11.4|10.6|660|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|2009
0-19|7.4|8.6|8.0|665|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|2009
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|2009
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|83280391|2009
0-14|9.9|11.5|10.7|654|IX Soft tissue and other extraosseous sarcomas|61087581|2009
0-19|11.4|12.9|12.1|1015|IX Soft tissue and other extraosseous sarcomas|83280391|2009
0-14|4.0|5.0|4.5|274|IX(a) Rhabdomyosarcomas|61087581|2009
0-19|3.8|4.7|4.2|352|IX(a) Rhabdomyosarcomas|83280391|2009
0-14|1.0|1.6|1.3|77|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|2009
0-19|1.3|1.8|1.5|128|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|2009
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61087581|2009
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83280391|2009
0-14|3.3|4.3|3.8|230|IX(d) Other specified soft tissue sarcomas|61087581|2009
0-19|4.4|5.4|4.9|414|IX(d) Other specified soft tissue sarcomas|83280391|2009
0-14|0.9|1.5|1.2|73|IX(e) Unspecified soft tissue sarcomas|61087581|2009
0-19|1.1|1.6|1.4|114|IX(e) Unspecified soft tissue sarcomas|83280391|2009
0-14|0.2|0.6|0.4|24|Not classified by ICCC|61087581|2009
0-19|0.3|0.5|0.4|32|Not classified by ICCC|83280391|2009
0-14|4.0|5.0|4.5|279|V Retinoblastoma|61087581|2009
0-19|3.0|3.8|3.3|279|V Retinoblastoma|83280391|2009
0-14|8.4|10.0|9.2|570|VI Renal tumors|61087581|2009
0-19|6.8|7.9|7.3|611|VI Renal tumors|83280391|2009
0-14|7.8|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|2009
0-19|6.0|7.1|6.5|542|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|2009
0-14|0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|2009
0-19|0.6|1.0|0.8|67|VI(b) Renal carcinomas|83280391|2009
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|2009
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|2009
0-14|1.8|2.6|2.2|137|VII Hepatic tumors|61087581|2009
0-19|1.7|2.3|2.0|167|VII Hepatic tumors|83280391|2009
0-14|1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|2009
0-19|1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|2009
0-14|0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|2009
0-19|0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|2009
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|2009
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|2009
0-14|6.4|7.7|7.0|426|VIII Malignant bone tumors|61087581|2009
0-19|8.3|9.6|8.9|750|VIII Malignant bone tumors|83280391|2009
0-14|3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|2009
0-19|4.6|5.5|5.0|423|VIII(a) Osteosarcomas|83280391|2009
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61087581|2009
0-19|0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|83280391|2009
0-14|2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61087581|2009
0-19|2.6|3.3|2.9|244|VIII(c) Ewing tumor and related sarcomas of bone|83280391|2009
0-14|0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|2009
0-19|0.3|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|83280391|2009
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|2009
0-19|0.1|0.3|0.2|18|VIII(e) Unspecified malignant bone tumors|83280391|2009
0-14|4.9|6.0|5.4|332|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|2009
0-19|10.8|12.2|11.5|987|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|2009
0-14|1.1|1.7|1.4|82|X(a) Intracranial & intraspinal germ cell tumors|61087581|2009
0-19|1.4|1.9|1.6|138|X(a) Intracranial & intraspinal germ cell tumors|83280391|2009
0-14|0.9|1.5|1.2|73|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|2009
0-19|1.1|1.6|1.3|114|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|2009
0-14|2.2|3.1|2.6|161|X(c) Malignant gonadal germ cell tumors|61087581|2009
0-19|7.0|8.1|7.5|653|X(c) Malignant gonadal germ cell tumors|83280391|2009
0-14|~|~|~|~|X(d) Gonadal carcinomas|61087581|2009
0-19|0.5|0.8|0.6|54|X(d) Gonadal carcinomas|83280391|2009
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|2009
0-19|0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|83280391|2009
0-14|6.5|7.9|7.2|435|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|2009
0-19|17.2|19.0|18.1|1560|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|2009
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|2009
0-19|0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|2009
0-14|2.5|3.3|2.9|175|XI(b) Thyroid carcinomas|61087581|2009
0-19|7.6|8.8|8.2|706|XI(b) Thyroid carcinomas|83280391|2009
0-14|0.3|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|61087581|2009
0-19|0.5|0.9|0.7|57|XI(c) Nasopharyngeal carcinomas|83280391|2009
0-14|1.4|2.0|1.7|103|XI(d) Malignant melanomas|61087581|2009
0-19|4.0|4.9|4.4|384|XI(d) Malignant melanomas|83280391|2009
0-14|~|~|~|~|XI(e) Skin carcinomas|61087581|2009
0-19|~|~|~|~|XI(e) Skin carcinomas|83280391|2009
0-14|1.5|2.3|1.9|114|XI(f) Other and unspecified carcinomas|61087581|2009
0-19|4.0|4.9|4.5|384|XI(f) Other and unspecified carcinomas|83280391|2009
0-14|0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|2009
0-19|0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|2009
0-14|0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|61087581|2009
0-19|0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|83280391|2009
0-14|0.3|0.7|0.5|29|XII(b) Other unspecified malignant tumors|61087581|2009
0-19|0.4|0.7|0.5|46|XII(b) Other unspecified malignant tumors|83280391|2009
0-14|165.3|171.8|168.5|10362|All ICCC Groups Combined|61201070|2010
0-19|177.0|182.8|179.9|15060|All ICCC Groups Combined|83180117|2010
0-14|52.2|55.9|54.0|3330|I Leukemias, myeloproliferative & myelodysplastic diseases|61201070|2010
0-19|47.2|50.2|48.7|4050|I Leukemias, myeloproliferative & myelodysplastic diseases|83180117|2010
0-14|39.2|42.4|40.8|2515|I(a) Lymphoid leukemias|61201070|2010
0-19|33.1|35.6|34.4|2852|I(a) Lymphoid leukemias|83180117|2010
0-14|6.8|8.2|7.5|461|I(b) Acute myeloid leukemias|61201070|2010
0-19|7.5|8.8|8.1|682|I(b) Acute myeloid leukemias|83180117|2010
0-14|1.6|2.4|2.0|121|I(c) Chronic myeloproliferative diseases|61201070|2010
0-19|2.3|3.0|2.6|222|I(c) Chronic myeloproliferative diseases|83180117|2010
0-14|1.7|2.4|2.0|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61201070|2010
0-19|1.6|2.2|1.9|159|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83180117|2010
0-14|1.4|2.1|1.7|108|I(e) Unspecified and other specified leukemias|61201070|2010
0-19|1.4|1.9|1.6|135|I(e) Unspecified and other specified leukemias|83180117|2010
0-14|18.8|21.0|19.9|1215|II Lymphomas and reticuloendothelial neoplasms|61201070|2010
0-19|26.3|28.5|27.4|2308|II Lymphomas and reticuloendothelial neoplasms|83180117|2010
0-14|4.7|5.9|5.3|322|II(a) Hodgkin lymphomas|61201070|2010
0-19|11.3|12.8|12.0|1024|II(a) Hodgkin lymphomas|83180117|2010
0-14|6.6|8.0|7.3|443|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61201070|2010
0-19|8.2|9.4|8.8|736|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83180117|2010
0-14|2.1|2.9|2.5|150|II(c) Burkitt lymphoma|61201070|2010
0-19|2.1|2.8|2.4|201|II(c) Burkitt lymphoma|83180117|2010
0-14|4.2|5.3|4.7|290|II(d) Miscellaneous lymphoreticular neoplasms|61201070|2010
0-19|3.4|4.3|3.8|318|II(d) Miscellaneous lymphoreticular neoplasms|83180117|2010
0-14|~|~|~|~|II(e) Unspecified lymphomas|61201070|2010
0-19|0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83180117|2010
0-14|33.9|36.9|35.4|2173|III CNS and misc intracranial and intraspinal neoplasms|61201070|2010
0-19|30.4|32.8|31.6|2615|III CNS and misc intracranial and intraspinal neoplasms|83180117|2010
0-14|2.8|3.7|3.2|200|III(a) Ependymomas and choroid plexus tumor|61201070|2010
0-19|2.4|3.2|2.8|232|III(a) Ependymomas and choroid plexus tumor|83180117|2010
0-14|16.9|19.0|17.9|1098|III(b) Astrocytomas|61201070|2010
0-19|15.5|17.3|16.4|1358|III(b) Astrocytomas|83180117|2010
0-14|6.7|8.1|7.3|452|III(c) Intracranial and intraspinal embryonal tumors|61201070|2010
0-19|5.5|6.6|6.0|500|III(c) Intracranial and intraspinal embryonal tumors|83180117|2010
0-14|5.3|6.5|5.9|360|III(d) Other gliomas|61201070|2010
0-19|4.9|5.9|5.4|447|III(d) Other gliomas|83180117|2010
0-14|0.5|0.9|0.7|40|III(e) Other specified intracranial & intraspinal neoplasms|61201070|2010
0-19|0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83180117|2010
0-14|0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61201070|2010
0-19|0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83180117|2010
0-14|10.3|12.0|11.1|692|IV Neuroblastoma and other peripheral nervous cell tumors|61201070|2010
0-19|7.9|9.2|8.5|710|IV Neuroblastoma and other peripheral nervous cell tumors|83180117|2010
0-14|10.2|11.8|11.0|682|IV(a) Neuroblastoma and ganglioneuroblastoma|61201070|2010
0-19|7.7|9.0|8.3|693|IV(a) Neuroblastoma and ganglioneuroblastoma|83180117|2010
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|61201070|2010
0-19|0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83180117|2010
0-14|10.6|12.4|11.5|703|IX Soft tissue and other extraosseous sarcomas|61201070|2010
0-19|11.9|13.4|12.7|1058|IX Soft tissue and other extraosseous sarcomas|83180117|2010
0-14|5.0|6.2|5.6|342|IX(a) Rhabdomyosarcomas|61201070|2010
0-19|4.8|5.8|5.3|437|IX(a) Rhabdomyosarcomas|83180117|2010
0-14|0.6|1.0|0.8|47|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61201070|2010
0-19|0.8|1.2|1.0|84|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83180117|2010
0-14|~|~|~|~|IX(c) Kaposi sarcoma|61201070|2010
0-19|~|~|~|~|IX(c) Kaposi sarcoma|83180117|2010
0-14|3.4|4.4|3.9|237|IX(d) Other specified soft tissue sarcomas|61201070|2010
0-19|4.3|5.2|4.7|395|IX(d) Other specified soft tissue sarcomas|83180117|2010
0-14|1.0|1.6|1.3|77|IX(e) Unspecified soft tissue sarcomas|61201070|2010
0-19|1.4|2.0|1.7|139|IX(e) Unspecified soft tissue sarcomas|83180117|2010
0-14|~|~|~|~|Not classified by ICCC|61201070|2010
0-19|0.1|0.4|0.2|20|Not classified by ICCC|83180117|2010
0-14|3.9|5.0|4.4|274|V Retinoblastoma|61201070|2010
0-19|2.9|3.7|3.3|274|V Retinoblastoma|83180117|2010
0-14|7.7|9.2|8.5|525|VI Renal tumors|61201070|2010
0-19|6.1|7.2|6.6|553|VI Renal tumors|83180117|2010
0-14|7.4|8.9|8.1|504|VI(a) Nephroblastoma and other nonepithelial renal tumors|61201070|2010
0-19|5.6|6.7|6.1|511|VI(a) Nephroblastoma and other nonepithelial renal tumors|83180117|2010
0-14|0.2|0.5|0.3|19|VI(b) Renal carcinomas|61201070|2010
0-19|0.3|0.6|0.5|40|VI(b) Renal carcinomas|83180117|2010
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|61201070|2010
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|83180117|2010
0-14|2.6|3.5|3.0|187|VII Hepatic tumors|61201070|2010
0-19|2.3|3.0|2.6|221|VII Hepatic tumors|83180117|2010
0-14|2.1|2.9|2.5|156|VII(a) Hepatoblastoma|61201070|2010
0-19|1.6|2.2|1.9|159|VII(a) Hepatoblastoma|83180117|2010
0-14|0.3|0.7|0.5|30|VII(b) Hepatic carcinomas|61201070|2010
0-19|0.5|0.9|0.7|60|VII(b) Hepatic carcinomas|83180117|2010
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61201070|2010
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83180117|2010
0-14|6.0|7.3|6.7|404|VIII Malignant bone tumors|61201070|2010
0-19|7.7|8.9|8.3|691|VIII Malignant bone tumors|83180117|2010
0-14|3.2|4.2|3.7|225|VIII(a) Osteosarcomas|61201070|2010
0-19|4.3|5.2|4.7|397|VIII(a) Osteosarcomas|83180117|2010
0-14|~|~|~|~|VIII(b) Chondrosarcomas|61201070|2010
0-19|0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|83180117|2010
0-14|2.0|2.8|2.3|142|VIII(c) Ewing tumor and related sarcomas of bone|61201070|2010
0-19|2.2|3.0|2.6|215|VIII(c) Ewing tumor and related sarcomas of bone|83180117|2010
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|61201070|2010
0-19|0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|83180117|2010
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|61201070|2010
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|83180117|2010
0-14|5.5|6.8|6.1|375|X Germ cell, trophoblastic tumors & neoplasms of gonads|61201070|2010
0-19|10.7|12.2|11.4|973|X Germ cell, trophoblastic tumors & neoplasms of gonads|83180117|2010
0-14|1.5|2.2|1.8|112|X(a) Intracranial & intraspinal germ cell tumors|61201070|2010
0-19|1.7|2.3|2.0|166|X(a) Intracranial & intraspinal germ cell tumors|83180117|2010
0-14|1.0|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61201070|2010
0-19|1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|83180117|2010
0-14|2.2|3.0|2.6|158|X(c) Malignant gonadal germ cell tumors|61201070|2010
0-19|6.7|7.8|7.2|621|X(c) Malignant gonadal germ cell tumors|83180117|2010
0-14|~|~|~|~|X(d) Gonadal carcinomas|61201070|2010
0-19|0.4|0.7|0.5|44|X(d) Gonadal carcinomas|83180117|2010
0-14|0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61201070|2010
0-19|0.3|0.5|0.4|33|X(e) Other and unspecified malignant gonadal tumors|83180117|2010
0-14|6.4|7.7|7.0|428|XI Other malignant epithelial neoplasms and malignant melanomas|61201070|2010
0-19|17.0|18.8|17.9|1528|XI Other malignant epithelial neoplasms and malignant melanomas|83180117|2010
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|61201070|2010
0-19|0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83180117|2010
0-14|2.3|3.2|2.8|167|XI(b) Thyroid carcinomas|61201070|2010
0-19|7.9|9.1|8.5|727|XI(b) Thyroid carcinomas|83180117|2010
0-14|0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61201070|2010
0-19|0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|83180117|2010
0-14|1.6|2.3|1.9|115|XI(d) Malignant melanomas|61201070|2010
0-19|3.6|4.5|4.1|346|XI(d) Malignant melanomas|83180117|2010
0-14|~|~|~|~|XI(e) Skin carcinomas|61201070|2010
0-19|~|~|~|~|XI(e) Skin carcinomas|83180117|2010
0-14|1.5|2.2|1.8|112|XI(f) Other and unspecified carcinomas|61201070|2010
0-19|4.0|4.9|4.4|377|XI(f) Other and unspecified carcinomas|83180117|2010
0-14|0.5|0.9|0.7|41|XII Other and unspecified malignant neoplasms|61201070|2010
0-19|0.5|0.9|0.7|59|XII Other and unspecified malignant neoplasms|83180117|2010
0-14|0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61201070|2010
0-19|0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|83180117|2010
0-14|0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|61201070|2010
0-19|0.2|0.5|0.3|28|XII(b) Other unspecified malignant tumors|83180117|2010
0-14|164.0|170.5|167.2|10176|All ICCC Groups Combined|60618763|2011
0-19|177.8|183.6|180.7|14918|All ICCC Groups Combined|82089424|2011
0-14|51.5|55.2|53.3|3253|I Leukemias, myeloproliferative & myelodysplastic diseases|60618763|2011
0-19|46.9|49.9|48.4|3973|I Leukemias, myeloproliferative & myelodysplastic diseases|82089424|2011
0-14|39.5|42.7|41.1|2507|I(a) Lymphoid leukemias|60618763|2011
0-19|33.9|36.4|35.1|2882|I(a) Lymphoid leukemias|82089424|2011
0-14|6.8|8.2|7.5|458|I(b) Acute myeloid leukemias|60618763|2011
0-19|7.5|8.7|8.1|669|I(b) Acute myeloid leukemias|82089424|2011
0-14|1.5|2.2|1.8|109|I(c) Chronic myeloproliferative diseases|60618763|2011
0-19|1.9|2.6|2.3|187|I(c) Chronic myeloproliferative diseases|82089424|2011
0-14|1.1|1.7|1.3|82|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60618763|2011
0-19|1.1|1.6|1.3|108|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82089424|2011
0-14|1.3|1.9|1.6|97|I(e) Unspecified and other specified leukemias|60618763|2011
0-19|1.3|1.8|1.5|127|I(e) Unspecified and other specified leukemias|82089424|2011
0-14|18.9|21.2|20.0|1212|II Lymphomas and reticuloendothelial neoplasms|60618763|2011
0-19|26.5|28.8|27.6|2292|II Lymphomas and reticuloendothelial neoplasms|82089424|2011
0-14|4.6|5.8|5.2|313|II(a) Hodgkin lymphomas|60618763|2011
0-19|11.1|12.6|11.8|990|II(a) Hodgkin lymphomas|82089424|2011
0-14|6.0|7.3|6.6|399|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60618763|2011
0-19|7.9|9.2|8.5|706|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82089424|2011
0-14|2.2|3.0|2.6|156|II(c) Burkitt lymphoma|60618763|2011
0-19|2.1|2.8|2.5|202|II(c) Burkitt lymphoma|82089424|2011
0-14|4.9|6.1|5.5|332|II(d) Miscellaneous lymphoreticular neoplasms|60618763|2011
0-19|4.0|5.0|4.5|366|II(d) Miscellaneous lymphoreticular neoplasms|82089424|2011
0-14|~|~|~|~|II(e) Unspecified lymphomas|60618763|2011
0-19|0.2|0.5|0.3|28|II(e) Unspecified lymphomas|82089424|2011
0-14|33.0|36.0|34.5|2095|III CNS and misc intracranial and intraspinal neoplasms|60618763|2011
0-19|30.8|33.2|32.0|2620|III CNS and misc intracranial and intraspinal neoplasms|82089424|2011
0-14|2.9|3.8|3.4|205|III(a) Ependymomas and choroid plexus tumor|60618763|2011
0-19|2.5|3.2|2.8|232|III(a) Ependymomas and choroid plexus tumor|82089424|2011
0-14|16.2|18.3|17.2|1046|III(b) Astrocytomas|60618763|2011
0-19|15.6|17.4|16.5|1352|III(b) Astrocytomas|82089424|2011
0-14|6.3|7.6|6.9|422|III(c) Intracranial and intraspinal embryonal tumors|60618763|2011
0-19|5.5|6.6|6.1|496|III(c) Intracranial and intraspinal embryonal tumors|82089424|2011
0-14|5.4|6.6|6.0|360|III(d) Other gliomas|60618763|2011
0-19|5.1|6.2|5.6|459|III(d) Other gliomas|82089424|2011
0-14|0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|60618763|2011
0-19|0.4|0.7|0.5|43|III(e) Other specified intracranial & intraspinal neoplasms|82089424|2011
0-14|0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60618763|2011
0-19|0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82089424|2011
0-14|10.3|12.0|11.1|681|IV Neuroblastoma and other peripheral nervous cell tumors|60618763|2011
0-19|7.9|9.1|8.5|696|IV Neuroblastoma and other peripheral nervous cell tumors|82089424|2011
0-14|10.1|11.8|10.9|669|IV(a) Neuroblastoma and ganglioneuroblastoma|60618763|2011
0-19|7.6|8.9|8.3|677|IV(a) Neuroblastoma and ganglioneuroblastoma|82089424|2011
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60618763|2011
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82089424|2011
0-14|10.1|11.8|11.0|666|IX Soft tissue and other extraosseous sarcomas|60618763|2011
0-19|11.2|12.8|12.0|988|IX Soft tissue and other extraosseous sarcomas|82089424|2011
0-14|4.6|5.8|5.2|315|IX(a) Rhabdomyosarcomas|60618763|2011
0-19|4.2|5.2|4.7|383|IX(a) Rhabdomyosarcomas|82089424|2011
0-14|0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60618763|2011
0-19|1.0|1.5|1.3|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82089424|2011
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60618763|2011
0-19|~|~|~|~|IX(c) Kaposi sarcoma|82089424|2011
0-14|3.2|4.2|3.7|223|IX(d) Other specified soft tissue sarcomas|60618763|2011
0-19|4.3|5.2|4.7|391|IX(d) Other specified soft tissue sarcomas|82089424|2011
0-14|0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60618763|2011
0-19|1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|82089424|2011
0-14|~|~|~|~|Not classified by ICCC|60618763|2011
0-19|0.2|0.5|0.3|27|Not classified by ICCC|82089424|2011
0-14|3.6|4.7|4.1|255|V Retinoblastoma|60618763|2011
0-19|2.7|3.5|3.1|255|V Retinoblastoma|82089424|2011
0-14|8.3|9.8|9.0|553|VI Renal tumors|60618763|2011
0-19|6.6|7.8|7.2|591|VI Renal tumors|82089424|2011
0-14|7.9|9.4|8.6|530|VI(a) Nephroblastoma and other nonepithelial renal tumors|60618763|2011
0-19|6.0|7.1|6.5|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|82089424|2011
0-14|0.2|0.6|0.4|22|VI(b) Renal carcinomas|60618763|2011
0-19|0.5|0.9|0.7|55|VI(b) Renal carcinomas|82089424|2011
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60618763|2011
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|82089424|2011
0-14|2.7|3.6|3.1|192|VII Hepatic tumors|60618763|2011
0-19|2.2|2.9|2.6|211|VII Hepatic tumors|82089424|2011
0-14|2.3|3.1|2.6|163|VII(a) Hepatoblastoma|60618763|2011
0-19|1.7|2.3|2.0|164|VII(a) Hepatoblastoma|82089424|2011
0-14|0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|60618763|2011
0-19|0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|82089424|2011
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60618763|2011
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82089424|2011
0-14|6.6|8.0|7.3|440|VIII Malignant bone tumors|60618763|2011
0-19|8.2|9.5|8.8|727|VIII Malignant bone tumors|82089424|2011
0-14|3.6|4.6|4.1|247|VIII(a) Osteosarcomas|60618763|2011
0-19|4.6|5.5|5.0|415|VIII(a) Osteosarcomas|82089424|2011
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60618763|2011
0-19|0.1|0.4|0.2|19|VIII(b) Chondrosarcomas|82089424|2011
0-14|2.4|3.2|2.8|168|VIII(c) Ewing tumor and related sarcomas of bone|60618763|2011
0-19|2.8|3.5|3.1|258|VIII(c) Ewing tumor and related sarcomas of bone|82089424|2011
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|60618763|2011
0-19|0.2|0.4|0.3|25|VIII(d) Other specified malignant bone tumors|82089424|2011
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60618763|2011
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|82089424|2011
0-14|4.5|5.6|5.0|305|X Germ cell, trophoblastic tumors & neoplasms of gonads|60618763|2011
0-19|9.9|11.4|10.6|891|X Germ cell, trophoblastic tumors & neoplasms of gonads|82089424|2011
0-14|1.2|1.8|1.5|90|X(a) Intracranial & intraspinal germ cell tumors|60618763|2011
0-19|1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82089424|2011
0-14|0.9|1.5|1.2|71|X(b) Malignant extracranial & extragonadal germ cell tumors|60618763|2011
0-19|1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|82089424|2011
0-14|1.8|2.6|2.2|131|X(c) Malignant gonadal germ cell tumors|60618763|2011
0-19|6.5|7.7|7.1|599|X(c) Malignant gonadal germ cell tumors|82089424|2011
0-14|~|~|~|~|X(d) Gonadal carcinomas|60618763|2011
0-19|0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82089424|2011
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60618763|2011
0-19|0.2|0.4|0.3|21|X(e) Other and unspecified malignant gonadal tumors|82089424|2011
0-14|7.1|8.5|7.8|470|XI Other malignant epithelial neoplasms and malignant melanomas|60618763|2011
0-19|18.0|19.9|19.0|1590|XI Other malignant epithelial neoplasms and malignant melanomas|82089424|2011
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60618763|2011
0-19|0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82089424|2011
0-14|2.8|3.7|3.3|196|XI(b) Thyroid carcinomas|60618763|2011
0-19|8.5|9.9|9.2|772|XI(b) Thyroid carcinomas|82089424|2011
0-14|0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|60618763|2011
0-19|0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82089424|2011
0-14|1.8|2.6|2.2|131|XI(d) Malignant melanomas|60618763|2011
0-19|3.9|4.8|4.4|365|XI(d) Malignant melanomas|82089424|2011
0-14|~|~|~|~|XI(e) Skin carcinomas|60618763|2011
0-19|~|~|~|~|XI(e) Skin carcinomas|82089424|2011
0-14|1.5|2.1|1.8|107|XI(f) Other and unspecified carcinomas|60618763|2011
0-19|4.0|4.9|4.5|374|XI(f) Other and unspecified carcinomas|82089424|2011
0-14|0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60618763|2011
0-19|0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|82089424|2011
0-14|0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|60618763|2011
0-19|0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82089424|2011
0-14|0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|60618763|2011
0-19|0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82089424|2011
0-14|160.8|167.3|164.0|9967|All ICCC Groups Combined|60580624|2012
0-19|176.7|182.5|179.6|14748|All ICCC Groups Combined|81757252|2012
0-14|49.2|52.8|51.0|3104|I Leukemias, myeloproliferative & myelodysplastic diseases|60580624|2012
0-19|44.9|47.9|46.4|3795|I Leukemias, myeloproliferative & myelodysplastic diseases|81757252|2012
0-14|37.5|40.7|39.1|2380|I(a) Lymphoid leukemias|60580624|2012
0-19|31.9|34.4|33.1|2709|I(a) Lymphoid leukemias|81757252|2012
0-14|6.4|7.7|7.0|426|I(b) Acute myeloid leukemias|60580624|2012
0-19|7.1|8.3|7.6|628|I(b) Acute myeloid leukemias|81757252|2012
0-14|1.2|1.8|1.5|91|I(c) Chronic myeloproliferative diseases|60580624|2012
0-19|1.9|2.6|2.2|185|I(c) Chronic myeloproliferative diseases|81757252|2012
0-14|1.3|1.9|1.6|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60580624|2012
0-19|1.2|1.7|1.5|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81757252|2012
0-14|1.5|2.2|1.8|112|I(e) Unspecified and other specified leukemias|60580624|2012
0-19|1.6|2.2|1.9|154|I(e) Unspecified and other specified leukemias|81757252|2012
0-14|19.7|22.0|20.8|1258|II Lymphomas and reticuloendothelial neoplasms|60580624|2012
0-19|27.9|30.2|29.1|2394|II Lymphomas and reticuloendothelial neoplasms|81757252|2012
0-14|5.1|6.3|5.6|340|II(a) Hodgkin lymphomas|60580624|2012
0-19|11.6|13.2|12.4|1028|II(a) Hodgkin lymphomas|81757252|2012
0-14|6.6|8.0|7.2|438|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60580624|2012
0-19|8.9|10.2|9.5|784|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81757252|2012
0-14|1.9|2.7|2.3|138|II(c) Burkitt lymphoma|60580624|2012
0-19|2.0|2.6|2.3|186|II(c) Burkitt lymphoma|81757252|2012
0-14|4.7|5.9|5.2|319|II(d) Miscellaneous lymphoreticular neoplasms|60580624|2012
0-19|4.0|4.9|4.4|360|II(d) Miscellaneous lymphoreticular neoplasms|81757252|2012
0-14|0.2|0.6|0.4|23|II(e) Unspecified lymphomas|60580624|2012
0-19|0.3|0.6|0.4|36|II(e) Unspecified lymphomas|81757252|2012
0-14|32.3|35.3|33.8|2050|III CNS and misc intracranial and intraspinal neoplasms|60580624|2012
0-19|29.6|32.0|30.8|2513|III CNS and misc intracranial and intraspinal neoplasms|81757252|2012
0-14|2.5|3.3|2.9|175|III(a) Ependymomas and choroid plexus tumor|60580624|2012
0-19|2.3|3.0|2.6|214|III(a) Ependymomas and choroid plexus tumor|81757252|2012
0-14|16.5|18.6|17.5|1064|III(b) Astrocytomas|60580624|2012
0-19|15.4|17.2|16.3|1329|III(b) Astrocytomas|81757252|2012
0-14|6.5|7.8|7.1|434|III(c) Intracranial and intraspinal embryonal tumors|60580624|2012
0-19|5.3|6.4|5.8|475|III(c) Intracranial and intraspinal embryonal tumors|81757252|2012
0-14|4.5|5.6|5.0|305|III(d) Other gliomas|60580624|2012
0-19|4.5|5.4|4.9|404|III(d) Other gliomas|81757252|2012
0-14|0.4|0.8|0.5|33|III(e) Other specified intracranial & intraspinal neoplasms|60580624|2012
0-19|0.4|0.7|0.5|43|III(e) Other specified intracranial & intraspinal neoplasms|81757252|2012
0-14|0.5|0.9|0.6|39|III(f) Unspecified intracranial and intraspinal neoplasms|60580624|2012
0-19|0.4|0.8|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|81757252|2012
0-14|10.3|12.0|11.1|678|IV Neuroblastoma and other peripheral nervous cell tumors|60580624|2012
0-19|7.9|9.2|8.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|81757252|2012
0-14|10.1|11.7|10.9|665|IV(a) Neuroblastoma and ganglioneuroblastoma|60580624|2012
0-19|7.7|8.9|8.3|676|IV(a) Neuroblastoma and ganglioneuroblastoma|81757252|2012
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|60580624|2012
0-19|0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|81757252|2012
0-14|10.0|11.6|10.8|653|IX Soft tissue and other extraosseous sarcomas|60580624|2012
0-19|10.7|12.2|11.5|939|IX Soft tissue and other extraosseous sarcomas|81757252|2012
0-14|4.4|5.5|4.9|299|IX(a) Rhabdomyosarcomas|60580624|2012
0-19|4.0|4.9|4.5|364|IX(a) Rhabdomyosarcomas|81757252|2012
0-14|0.9|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60580624|2012
0-19|1.0|1.5|1.2|98|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81757252|2012
0-14|~|~|~|~|IX(c) Kaposi sarcoma|60580624|2012
0-19|~|~|~|~|IX(c) Kaposi sarcoma|81757252|2012
0-14|3.0|4.0|3.5|210|IX(d) Other specified soft tissue sarcomas|60580624|2012
0-19|3.9|4.8|4.3|357|IX(d) Other specified soft tissue sarcomas|81757252|2012
0-14|1.0|1.5|1.2|74|IX(e) Unspecified soft tissue sarcomas|60580624|2012
0-19|1.1|1.7|1.4|114|IX(e) Unspecified soft tissue sarcomas|81757252|2012
0-14|~|~|~|~|Not classified by ICCC|60580624|2012
0-19|0.1|0.4|0.2|19|Not classified by ICCC|81757252|2012
0-14|3.8|4.9|4.3|263|V Retinoblastoma|60580624|2012
0-19|2.9|3.6|3.2|264|V Retinoblastoma|81757252|2012
0-14|7.7|9.2|8.4|516|VI Renal tumors|60580624|2012
0-19|6.4|7.5|6.9|566|VI Renal tumors|81757252|2012
0-14|7.3|8.8|8.0|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|60580624|2012
0-19|5.6|6.7|6.1|502|VI(a) Nephroblastoma and other nonepithelial renal tumors|81757252|2012
0-14|0.2|0.5|0.3|18|VI(b) Renal carcinomas|60580624|2012
0-19|0.5|0.9|0.7|58|VI(b) Renal carcinomas|81757252|2012
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|60580624|2012
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|81757252|2012
0-14|2.8|3.8|3.3|201|VII Hepatic tumors|60580624|2012
0-19|2.4|3.1|2.7|225|VII Hepatic tumors|81757252|2012
0-14|2.4|3.3|2.8|173|VII(a) Hepatoblastoma|60580624|2012
0-19|1.8|2.5|2.1|174|VII(a) Hepatoblastoma|81757252|2012
0-14|0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|60580624|2012
0-19|0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81757252|2012
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60580624|2012
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81757252|2012
0-14|6.5|7.8|7.1|429|VIII Malignant bone tumors|60580624|2012
0-19|8.2|9.5|8.8|721|VIII Malignant bone tumors|81757252|2012
0-14|3.8|4.9|4.3|260|VIII(a) Osteosarcomas|60580624|2012
0-19|4.7|5.6|5.1|420|VIII(a) Osteosarcomas|81757252|2012
0-14|~|~|~|~|VIII(b) Chondrosarcomas|60580624|2012
0-19|0.2|0.5|0.3|26|VIII(b) Chondrosarcomas|81757252|2012
0-14|1.8|2.6|2.2|132|VIII(c) Ewing tumor and related sarcomas of bone|60580624|2012
0-19|2.4|3.1|2.7|225|VIII(c) Ewing tumor and related sarcomas of bone|81757252|2012
0-14|0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60580624|2012
0-19|0.2|0.5|0.4|30|VIII(d) Other specified malignant bone tumors|81757252|2012
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|60580624|2012
0-19|0.1|0.4|0.2|20|VIII(e) Unspecified malignant bone tumors|81757252|2012
0-14|4.5|5.6|5.0|304|X Germ cell, trophoblastic tumors & neoplasms of gonads|60580624|2012
0-19|10.7|12.1|11.4|945|X Germ cell, trophoblastic tumors & neoplasms of gonads|81757252|2012
0-14|1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60580624|2012
0-19|1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|81757252|2012
0-14|1.1|1.8|1.4|87|X(b) Malignant extracranial & extragonadal germ cell tumors|60580624|2012
0-19|1.4|1.9|1.6|133|X(b) Malignant extracranial & extragonadal germ cell tumors|81757252|2012
0-14|1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|60580624|2012
0-19|6.9|8.1|7.5|623|X(c) Malignant gonadal germ cell tumors|81757252|2012
0-14|~|~|~|~|X(d) Gonadal carcinomas|60580624|2012
0-19|0.3|0.6|0.4|35|X(d) Gonadal carcinomas|81757252|2012
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60580624|2012
0-19|0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81757252|2012
0-14|6.9|8.3|7.5|455|XI Other malignant epithelial neoplasms and malignant melanomas|60580624|2012
0-19|18.3|20.2|19.2|1599|XI Other malignant epithelial neoplasms and malignant melanomas|81757252|2012
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|60580624|2012
0-19|0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|81757252|2012
0-14|2.8|3.7|3.3|196|XI(b) Thyroid carcinomas|60580624|2012
0-19|8.9|10.2|9.5|792|XI(b) Thyroid carcinomas|81757252|2012
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|60580624|2012
0-19|0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|81757252|2012
0-14|1.6|2.3|1.9|114|XI(d) Malignant melanomas|60580624|2012
0-19|3.7|4.6|4.1|342|XI(d) Malignant melanomas|81757252|2012
0-14|~|~|~|~|XI(e) Skin carcinomas|60580624|2012
0-19|~|~|~|~|XI(e) Skin carcinomas|81757252|2012
0-14|1.6|2.3|1.9|115|XI(f) Other and unspecified carcinomas|60580624|2012
0-19|4.3|5.3|4.8|398|XI(f) Other and unspecified carcinomas|81757252|2012
0-14|0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|60580624|2012
0-19|0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|81757252|2012
0-14|0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|60580624|2012
0-19|0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|81757252|2012
0-14|0.2|0.6|0.4|23|XII(b) Other unspecified malignant tumors|60580624|2012
0-19|0.4|0.7|0.5|42|XII(b) Other unspecified malignant tumors|81757252|2012
